{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:22:09Z","timestamp":1771464129496,"version":"3.50.1"},"reference-count":303,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolic bone disorders and associated fragility fractures are major causes of disability and mortality worldwide and place an important financial burden on the global health systems. These disorders result from an unbalance between bone anabolic and resorptive processes and are characterized by different pathophysiological mechanisms. Drugs are available to treat bone metabolic pathologies, but they are either poorly effective or associated with undesired side effects that limit their use. The molecular mechanism underlying the most common metabolic bone disorders, and the availability, efficacy, and limitations of therapeutic options currently available are discussed here. A source for the unmet need of novel drugs to treat metabolic bone disorders is marine organisms, which produce natural osteoactive compounds of high pharmaceutical potential. In this review, we have inventoried the marine osteoactive compounds (MOCs) currently identified and spotted the groups of marine organisms with potential for MOC production. Finally, we briefly examine the availability of in vivo screening and validation tools for the study of MOCs.<\/jats:p>","DOI":"10.1007\/s00018-023-05033-x","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T15:02:06Z","timestamp":1703084526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Metabolic bone disorders and the promise of marine osteoactive compounds"],"prefix":"10.1007","volume":"81","author":[{"given":"Alessio","family":"Carletti","sequence":"first","affiliation":[]},{"given":"Paulo Jorge","family":"Gavaia","sequence":"additional","affiliation":[]},{"given":"Maria Leonor","family":"Cancela","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-9198","authenticated-orcid":false,"given":"Vincent","family":"Laiz\u00e9","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"5033_CR1","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","volume":"2","author":"A-M Wu","year":"2021","unstructured":"Wu A-M et al (2021) Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: A systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev 2:e580\u2013e592","journal-title":"Lancet Healthy Longev"},{"key":"5033_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","volume":"6","author":"X Feng","year":"2011","unstructured":"Feng X, McDonald JM (2011) Disorders of bone remodeling. Annu Rev Pathol Mech Dis 6:121\u2013145","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"5033_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2967\/jnumed.120.256180","volume":"62","author":"KN Haseltine","year":"2021","unstructured":"Haseltine KN, Chukir T, Smith PJ, Jacob JT, Bilezikian JP, Farooki A (2021) Bone mineral density: Clinical relevance and quantitative assessment. J Nucl Med 62:446\u2013454","journal-title":"J Nucl Med"},{"key":"5033_CR4","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1007\/s00198-017-4153-6","volume":"28","author":"S Williamson","year":"2017","unstructured":"Williamson S et al (2017) Costs of fragility hip fractures globally: A systematic review and meta-regression analysis. Osteoporos Int 28:2791\u20132800","journal-title":"Osteoporos Int"},{"key":"5033_CR5","first-page":"180","volume":"10","author":"M Saghafi","year":"2013","unstructured":"Saghafi M, Azarian A, Hashemzadeh K, Sahebari M, Rezaieyazdi Z (2013) Bone densitometry in patients with osteomalacia: Is it valuable? Clin Cases Miner Bone Metab 10:180\u2013182","journal-title":"Clin Cases Miner Bone Metab"},{"key":"5033_CR6","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1210\/jc.2014-2092","volume":"99","author":"TD Thacher","year":"2014","unstructured":"Thacher TD, Fischer PR, Pettifor JM (2014) The effect of nutritional rickets on bone mineral density. J Clin Endocrinol Metab 99:4174\u20134180","journal-title":"J Clin Endocrinol Metab"},{"key":"5033_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.18773\/austprescr.2016.020","volume":"39","author":"A Sheu","year":"2016","unstructured":"Sheu A, Diamond T (2016) Bone mineral density: Testing for osteoporosis. Aust Prescr 39:35\u201339","journal-title":"Aust Prescr"},{"key":"5033_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jbmr.2715","volume":"31","author":"M Arruda","year":"2016","unstructured":"Arruda M et al (2016) Bone mineral density and microarchitecture in patients with autosomal dominant osteopetrosis: A report of two cases. J Bone Miner Res 31:657\u2013662","journal-title":"J Bone Miner Res"},{"key":"5033_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/qjmed\/hcaa155","volume":"114","author":"L Tripto-Shkolnik","year":"2021","unstructured":"Tripto-Shkolnik L, Liel Y (2021) Paget\u2019s disease on bone mineral density examination. QJM Int J Med 114:60\u201361","journal-title":"QJM Int J Med"},{"key":"5033_CR10","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00198-014-2689-2","volume":"25","author":"E Koumakis","year":"2014","unstructured":"Koumakis E et al (2014) Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism. Osteoporos Int 25:1963\u20131968","journal-title":"Osteoporos Int"},{"key":"5033_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1681\/ASN.2010121253","volume":"23","author":"HH Malluche","year":"2012","unstructured":"Malluche HH, Porter DS, Monier-Faugere M-C, Mawad H, Pienkowski D (2012) Differences in bone quality in low- and high-turnover renal osteodystrophy. J Am Soc Nephrol JASN 23:525\u2013532","journal-title":"J Am Soc Nephrol JASN"},{"key":"5033_CR12","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1111\/j.1753-4887.2008.00100.x","volume":"66","author":"A Prentice","year":"2008","unstructured":"Prentice A (2008) Vitamin D deficiency: A global perspective. Nutr Rev 66:S153\u2013S164","journal-title":"Nutr Rev"},{"key":"5033_CR13","doi-asserted-by":"publisher","first-page":"a031237","DOI":"10.1101\/cshperspect.a031237","volume":"8","author":"MN Wein","year":"2018","unstructured":"Wein MN, Kronenberg HM (2018) Regulation of bone remodeling by parathyroid hormone. Cold Spring Harb Perspect Med 8:a031237","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5033_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ecl.2010.02.001","volume":"39","author":"A Bhan","year":"2010","unstructured":"Bhan A, Rao AD, Rao DS (2010) Osteomalacia as a result of vitamin D deficiency. Endocrinol Metab Clin 39:321\u2013331","journal-title":"Endocrinol Metab Clin"},{"key":"5033_CR15","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(13)61650-5","volume":"383","author":"CJ Elder","year":"2014","unstructured":"Elder CJ, Bishop NJ (2014) Rickets. The Lancet 383:1665\u20131676","journal-title":"The Lancet"},{"key":"5033_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14:115\u2013125","journal-title":"Nat Rev Endocrinol"},{"key":"5033_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","volume":"69","author":"L Mosekilde","year":"2008","unstructured":"Mosekilde L (2008) Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69:1\u201319","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5033_CR18","first-page":"117","volume":"18","author":"G Coen","year":"2005","unstructured":"Coen G (2005) Adynamic bone disease: An update and overview. J Nephrol 18:117\u2013122","journal-title":"J Nephrol"},{"key":"5033_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000072552","volume":"21","author":"E Slatopolsky","year":"2003","unstructured":"Slatopolsky E, Gonzalez E, Martin K (2003) Pathogenesis and treatment of renal osteodystrophy. Blood Purif 21:318\u2013326","journal-title":"Blood Purif"},{"key":"5033_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N et al (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg 16:609","journal-title":"J Orthop Surg"},{"key":"5033_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.2002.17.3.465","volume":"17","author":"TP Van Staa","year":"2002","unstructured":"Van Staa TP et al (2002) Incidence and natural history of Paget\u2019s disease of bone in England and Wales. J Bone Miner Res 17:465\u2013471","journal-title":"J Bone Miner Res"},{"key":"5033_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.beem.2018.05.005","volume":"32","author":"NM Appelman-Dijkstra","year":"2018","unstructured":"Appelman-Dijkstra NM, Papapoulos SE (2018) Paget\u2019s disease of bone. Best Pract Res Clin Endocrinol Metab 32:657\u2013668","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5033_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00223-019-00522-3","volume":"104","author":"L Gennari","year":"2019","unstructured":"Gennari L, Rendina D, Falchetti A, Merlotti D (2019) Paget\u2019s disease of bone. Calcif Tissue Int 104:483\u2013500","journal-title":"Calcif Tissue Int"},{"key":"5033_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11882-021-01001-2","volume":"21","author":"EM Rabjohns","year":"2021","unstructured":"Rabjohns EM et al (2021) Paget\u2019s disease of bone: Osteoimmunology and osteoclast pathology. Curr Allergy Asthma Rep 21:23","journal-title":"Curr Allergy Asthma Rep"},{"key":"5033_CR25","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/art.1780231005","volume":"23","author":"PJ Meunier","year":"1980","unstructured":"Meunier PJ, Coindre JM, Edouard CM, Arlot ME (1980) Bone histomorphometry in Paget\u2019s disease: Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthritis Rheum 23:1095\u20131103","journal-title":"Arthritis Rheum"},{"key":"5033_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jbmr.5650140204","volume":"14","author":"P Gehron Robey","year":"1999","unstructured":"Gehron Robey P, Bianco P (1999) The role of osteogenic cells in the pathophysiology of Paget\u2019s disease. J Bone Miner Res 14:9\u201316","journal-title":"J Bone Miner Res"},{"key":"5033_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrendo.2015.138","volume":"11","author":"FR Singer","year":"2015","unstructured":"Singer FR (2015) Paget\u2019s disease of bone-Genetic and environmental factors. Nat Rev Endocrinol 11:662\u2013671","journal-title":"Nat Rev Endocrinol"},{"key":"5033_CR28","doi-asserted-by":"publisher","first-page":"e0271555","DOI":"10.1371\/journal.pone.0271555","volume":"17","author":"HH Malluche","year":"2022","unstructured":"Malluche HH, Davenport DL, Lima F, Monier-Faugere M-C (2022) Prevalence of low bone formation in untreated patients with osteoporosis. PLoS One 17:e0271555","journal-title":"PLoS One"},{"key":"5033_CR29","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s10495-013-0867-x","volume":"18","author":"Y-H Yang","year":"2013","unstructured":"Yang Y-H et al (2013) Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER\u2013ERK\u2013mTOR pathway. Apoptosis 18:1363\u20131375","journal-title":"Apoptosis"},{"key":"5033_CR30","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bone.2006.10.014","volume":"40","author":"V Mann","year":"2007","unstructured":"Mann V, Huber C, Kogianni G, Collins F, Noble B (2007) The antioxidant effect of estrogen and selective estrogen receptor modulators in the inhibition of osteocyte apoptosis in vitro. Bone 40:674\u2013684","journal-title":"Bone"},{"key":"5033_CR31","doi-asserted-by":"publisher","first-page":"7829","DOI":"10.1073\/pnas.130200197","volume":"97","author":"NK Shevde","year":"2000","unstructured":"Shevde NK, Bendixen AC, Dienger KM, Pike JW (2000) Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci 97:7829\u20137834","journal-title":"Proc Natl Acad Sci"},{"key":"5033_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/cmi.2010.54","volume":"8","author":"CY Luo","year":"2011","unstructured":"Luo CY, Wang L, Sun C, Li DJ (2011) Estrogen enhances the functions of CD4+CD25+Foxp3+ regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol 8:50\u201358","journal-title":"Cell Mol Immunol"},{"key":"5033_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/sj.emboj.7601984","volume":"27","author":"SA Krum","year":"2008","unstructured":"Krum SA et al (2008) Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J 27:535\u2013545","journal-title":"EMBO J"},{"key":"5033_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1600-0897.1996.tb00176.x","volume":"36","author":"AG Rijhsinghani","year":"1996","unstructured":"Rijhsinghani AG, Thompson K, Bhatia SK, Waldschmidt TJ (1996) Estrogen blocks early T cell development in the thymus. Am J Reprod Immunol 36:269\u2013277","journal-title":"Am J Reprod Immunol"},{"key":"5033_CR35","doi-asserted-by":"publisher","first-page":"687551","DOI":"10.3389\/fimmu.2021.687551","volume":"12","author":"D Wu","year":"2021","unstructured":"Wu D et al (2021) T-cell mediated inflammation in postmenopausal osteoporosis. Front Immunol 12:687551","journal-title":"Front Immunol"},{"key":"5033_CR36","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: An inflammatory tale. J Clin Invest 116:1186\u20131194","journal-title":"J Clin Invest"},{"key":"5033_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s001980200001","volume":"13","author":"L Warming","year":"2002","unstructured":"Warming L, Hassager C, Christiansen C (2002) Changes in bone mineral density with age in men and women: A longitudinal study. Osteoporos Int 13:105\u2013112","journal-title":"Osteoporos Int"},{"key":"5033_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/er.2009-0024","volume":"31","author":"SC Manolagas","year":"2010","unstructured":"Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266\u2013300","journal-title":"Endocr Rev"},{"key":"5033_CR39","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.3390\/ijms20143576","volume":"20","author":"TS Agidigbi","year":"2019","unstructured":"Agidigbi TS, Kim C (2019) Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci 20:3576","journal-title":"Int J Mol Sci"},{"key":"5033_CR40","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1177\/0748233713491801","volume":"31","author":"B Zhang","year":"2015","unstructured":"Zhang B, Xie Q, Quan Y, Pan X, Liao D (2015) Reactive oxygen species induce cell death via Akt signaling in rat osteoblast-like cell line ROS 17\/28. Toxicol Ind Health 31:1236\u20131242","journal-title":"Toxicol Ind Health"},{"key":"5033_CR41","unstructured":"Porter JL, Varacallo M (2023) Osteoporosis. in StatPearls (StatPearls Publishing)"},{"key":"5033_CR42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00223-021-00836-1","volume":"110","author":"T Rolvien","year":"2022","unstructured":"Rolvien T, Amling M (2022) Disuse osteoporosis: Clinical and mechanistic insights. Calcif Tissue Int 110:592\u2013604","journal-title":"Calcif Tissue Int"},{"key":"5033_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/1759720X14546350","volume":"6","author":"K Panday","year":"2014","unstructured":"Panday K, Gona A, Humphrey MB (2014) Medication-induced osteoporosis: Screening and treatment strategies. Ther Adv Musculoskelet Dis 6:185\u2013202","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5033_CR44","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.3390\/ijms24065814","volume":"24","author":"L-T Wang","year":"2023","unstructured":"Wang L-T, Chen L-R, Chen K-H (2023) Hormone-related and drug-induced osteoporosis: A cellular and molecular overview. Int J Mol Sci 24:5814","journal-title":"Int J Mol Sci"},{"key":"5033_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","volume":"16","author":"P Chotiyarnwong","year":"2020","unstructured":"Chotiyarnwong P, McCloskey EV (2020) Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol 16:437\u2013447","journal-title":"Nat Rev Endocrinol"},{"key":"5033_CR46","first-page":"4307","volume":"17","author":"S Zhang","year":"2018","unstructured":"Zhang S, Liu Y, Liang Q (2018) Low-dose dexamethasone affects osteoblast viability by inducing autophagy via intracellular ROS. Mol Med Rep 17:4307\u20134316","journal-title":"Mol Med Rep"},{"key":"5033_CR47","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1210\/mend.15.10.0704","volume":"15","author":"AM Delany","year":"2001","unstructured":"Delany AM, Durant D, Canalis E (2001) Glucocorticoid suppression of IGF-I transcription in osteoblasts. Mol Endocrinol 15:1781\u20131789","journal-title":"Mol Endocrinol"},{"key":"5033_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1172\/JCI113885","volume":"83","author":"E Canalis","year":"1989","unstructured":"Canalis E, Centrella M, Burch W, McCarthy TL (1989) Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60\u201365","journal-title":"J Clin Invest"},{"key":"5033_CR49","doi-asserted-by":"publisher","first-page":"E587","DOI":"10.1152\/ajpendo.00219.2016","volume":"311","author":"M Piemontese","year":"2016","unstructured":"Piemontese M, Xiong J, Fujiwara Y, Thostenson JD, O\u2019Brien CA (2016) Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. Am J Physiol-Endocrinol Metab 311:E587\u2013E593","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"5033_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-4-5","volume":"4","author":"Z Stark","year":"2009","unstructured":"Stark Z, Savarirayan R (2009) Osteopetrosis. Orphanet J Rare Dis 4:5","journal-title":"Orphanet J Rare Dis"},{"key":"5033_CR51","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/cimb45020089","volume":"45","author":"Z Alkhayal","year":"2023","unstructured":"Alkhayal Z, Shinwari Z, Gaafar A, Alaiya A (2023) Carbonic anhydrase II activators in osteopetrosis treatment: A review. Curr Issues Mol Biol 45:1373\u20131386","journal-title":"Curr Issues Mol Biol"},{"key":"5033_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11914-018-0415-2","volume":"16","author":"E Palagano","year":"2018","unstructured":"Palagano E, Menale C, Sobacchi C, Villa A (2018) Genetics of osteopetrosis. Curr Osteoporos Rep 16:13\u201325","journal-title":"Curr Osteoporos Rep"},{"key":"5033_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0002-9343(57)90011-6","volume":"22","author":"DH Copp","year":"1957","unstructured":"Copp DH (1957) Calcium and phosphorus metabolism. Am J Med 22:275\u2013285","journal-title":"Am J Med"},{"key":"5033_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0021-9258(18)85783-0","volume":"53","author":"EV McCollum","year":"1922","unstructured":"McCollum EV, Simmonds N, Becker JE, Shipley PG (1922) Studies on experimental rickets: xxi. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 53:293\u2013312","journal-title":"J Biol Chem"},{"key":"5033_CR55","doi-asserted-by":"publisher","first-page":"691","DOI":"10.7326\/0003-4819-158-6-201303190-00588","volume":"158","author":"VA Moyer","year":"2013","unstructured":"Moyer VA (2013) Vitamin D and calcium supplementation to prevent fractures in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 158:691\u2013696","journal-title":"Ann Intern Med"},{"key":"5033_CR56","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1001\/jama.2017.19344","volume":"318","author":"J-G Zhao","year":"2017","unstructured":"Zhao J-G, Zeng X-T, Wang J, Liu L (2017) Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: A systematic review and meta-analysis. JAMA 318:2466\u20132482","journal-title":"JAMA"},{"key":"5033_CR57","doi-asserted-by":"publisher","first-page":"468","DOI":"10.5694\/mja2.50393","volume":"211","author":"IR Reid","year":"2019","unstructured":"Reid IR, Bolland MJ (2019) Controversies in medicine: The role of calcium and vitamin D supplements in adults. Med J Aust 211:468\u2013473","journal-title":"Med J Aust"},{"key":"5033_CR58","doi-asserted-by":"publisher","first-page":"h4183","DOI":"10.1136\/bmj.h4183","volume":"351","author":"V Tai","year":"2015","unstructured":"Tai V, Leung W, Grey A, Reid IR, Bolland MJ (2015) Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ 351:h4183","journal-title":"BMJ"},{"key":"5033_CR59","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1210\/er.2001-7002","volume":"23","author":"B Shea","year":"2002","unstructured":"Shea B et al (2002) VII Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 23:552\u2013559","journal-title":"Endocr Rev"},{"key":"5033_CR60","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archinte.166.8.869","volume":"166","author":"RL Prince","year":"2006","unstructured":"Prince RL et al (2006) Effects of calcium supplementation on clinical fracture and bone structure: Results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166:869\u2013875","journal-title":"Arch Intern Med"},{"key":"5033_CR61","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/nu13020368","volume":"13","author":"S-K Myung","year":"2021","unstructured":"Myung S-K, Kim H-B, Lee Y-J, Choi Y-J, Oh S-W (2021) Calcium supplements and risk of cardiovascular disease: A meta-analysis of clinical trials. Nutrients 13:368","journal-title":"Nutrients"},{"key":"5033_CR62","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12603-020-1551-9","volume":"25","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) Association of vitamin D or calcium supplementation with cardiovascular outcomes and mortality: A meta-analysis with trial sequential analysis. J Nutr Health Aging 25:263\u2013270","journal-title":"J Nutr Health Aging"},{"key":"5033_CR63","first-page":"873","volume":"72","author":"R Omelka","year":"2021","unstructured":"Omelka R et al (2021) Chicken eggshell powder more effectively alleviates bone loss comparted to inorganic calcium carbonate: An animal study performed on ovariectomized rats. J Physiol Pharmacol 72:873\u2013879","journal-title":"J Physiol Pharmacol"},{"key":"5033_CR64","doi-asserted-by":"publisher","first-page":"c7254","DOI":"10.1136\/bmj.c7254","volume":"342","author":"T Winzenberg","year":"2011","unstructured":"Winzenberg T, Powell S, Shaw KA, Jones G (2011) Effects of vitamin D supplementation on bone density in healthy children: Systematic review and meta-analysis. BMJ 342:c7254","journal-title":"BMJ"},{"key":"5033_CR65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41574-021-00593-z","volume":"18","author":"R Bouillon","year":"2022","unstructured":"Bouillon R et al (2022) The health effects of vitamin D supplementation: Evidence from human studies. Nat Rev Endocrinol 18:96\u2013110","journal-title":"Nat Rev Endocrinol"},{"key":"5033_CR66","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00132-017-3446-y","volume":"46","author":"H Wu","year":"2017","unstructured":"Wu H, Pang Q (2017) The effect of vitamin D and calcium supplementation on falls in older adults. Orthop 46:729\u2013736","journal-title":"Orthop"},{"key":"5033_CR67","doi-asserted-by":"publisher","first-page":"10817","DOI":"10.1039\/D0FO00787K","volume":"11","author":"C Liu","year":"2020","unstructured":"Liu C et al (2020) Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials. Food Funct 11:10817\u201310827","journal-title":"Food Funct"},{"key":"5033_CR68","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/S0140-6736(05)63013-9","volume":"365","author":"AM Grant","year":"2005","unstructured":"Grant AM et al (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): A randomised placebo-controlled trial. The Lancet 365:1621\u20131628","journal-title":"The Lancet"},{"key":"5033_CR69","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/joim.12825","volume":"284","author":"LM Smith","year":"2018","unstructured":"Smith LM, Gallagher JC, Kaufmann M, Jones G (2018) Effect of increasing doses of vitamin D on bone mineral density and serum N-terminal telopeptide in elderly women: A randomized controlled trial. J Intern Med 284:685\u2013693","journal-title":"J Intern Med"},{"key":"5033_CR70","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11657-020-00842-0","volume":"15","author":"JD Ringe","year":"2020","unstructured":"Ringe JD (2020) Plain vitamin D or active vitamin D in the treatment of osteoporosis: Where do we stand today? Arch Osteoporos 15:182","journal-title":"Arch Osteoporos"},{"key":"5033_CR71","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11914-017-0383-y","volume":"15","author":"S Uday","year":"2017","unstructured":"Uday S, H\u00f6gler W (2017) Nutritional rickets and osteomalacia in the twenty-first century: Revised concepts, public health, and prevention strategies. Curr Osteoporos Rep 15:293\u2013302","journal-title":"Curr Osteoporos Rep"},{"key":"5033_CR72","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jocd.2005.11.001","volume":"9","author":"R Bhambri","year":"2006","unstructured":"Bhambri R et al (2006) Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom 9:120\u2013127","journal-title":"J Clin Densitom"},{"key":"5033_CR73","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s11255-019-02271-6","volume":"51","author":"J Xu","year":"2019","unstructured":"Xu J, Yang Y, Ma L, Fu P, Peng H (2019) Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: A meta-analysis of randomized controlled trials. Int Urol Nephrol 51:2027\u20132036","journal-title":"Int Urol Nephrol"},{"key":"5033_CR74","doi-asserted-by":"publisher","first-page":"e14455","DOI":"10.1097\/MD.0000000000014455","volume":"98","author":"T Xing","year":"2019","unstructured":"Xing T, Hu Y, Wang B, Zhu J (2019) Role of oral calcium supplementation alone or with vitamin D in preventing post-thyroidectomy hypocalcaemia: A meta-analysis. Medicine (Baltimore) 98:e14455","journal-title":"Medicine (Baltimore)"},{"key":"5033_CR75","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00223-019-00578-1","volume":"105","author":"D Rendina","year":"2019","unstructured":"Rendina D et al (2019) Vitamin D status in Paget disease of bone and efficacy\u2013safety profile of cholecalciferol treatment in pagetic patients with hypovitaminosis D. Calcif Tissue Int 105:412\u2013422","journal-title":"Calcif Tissue Int"},{"key":"5033_CR76","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1210\/clinem\/dgz138","volume":"105","author":"D Merlotti","year":"2020","unstructured":"Merlotti D et al (2020) Preventive role of vitamin D supplementation for acute phase reaction after bisphosphonate infusion in Paget\u2019s disease. J Clin Endocrinol Metab 105:e466\u2013e476","journal-title":"J Clin Endocrinol Metab"},{"key":"5033_CR77","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/BF02073378","volume":"152","author":"EM van Lie Peters","year":"1993","unstructured":"van Lie Peters EM, Aronson DC, Everts V, Dooren LJ (1993) Failure of calcitriol treatment in a patient with malignant osteopetrosis. Eu. J Pediatr 152:818\u2013821","journal-title":"Eu. J Pediatr"},{"key":"5033_CR78","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1210\/jc.2017-01127","volume":"102","author":"CC Wu","year":"2017","unstructured":"Wu CC et al (2017) Diagnosis and management of osteopetrosis: Consensus guidelines from the osteopetrosis working group. J Clin Endocrinol Metab 102:3111\u20133123","journal-title":"J Clin Endocrinol Metab"},{"key":"5033_CR79","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.3390\/nu12123625","volume":"12","author":"M Fusaro","year":"2020","unstructured":"Fusaro M et al (2020) Vitamin K and osteoporosis. Nutrients 12:3625","journal-title":"Nutrients"},{"key":"5033_CR80","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/nu12030780","volume":"12","author":"S Araki","year":"2020","unstructured":"Araki S, Shirahata A (2020) Vitamin K deficiency bleeding in infancy. Nutrients 12:780","journal-title":"Nutrients"},{"key":"5033_CR81","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1053\/j.ackd.2019.10.005","volume":"26","author":"M Cozzolino","year":"2019","unstructured":"Cozzolino M, Fusaro M, Ciceri P, Gasperoni L, Cianciolo G (2019) The role of vitamin K in vascular calcification. Adv Chronic Kidney Dis 26:437\u2013444","journal-title":"Adv Chronic Kidney Dis"},{"key":"5033_CR82","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jbmr.3608","volume":"34","author":"P Evenepoel","year":"2019","unstructured":"Evenepoel P et al (2019) Poor vitamin K status is associated with low bone mineral density and increased fracture risk in end-stage renal disease. J Bone Miner Res 34:262\u2013269","journal-title":"J Bone Miner Res"},{"key":"5033_CR83","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.nut.2010.10.021","volume":"27","author":"S Nakajima","year":"2011","unstructured":"Nakajima S et al (2011) Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease. Nutrition 27:1023\u20131028","journal-title":"Nutrition"},{"key":"5033_CR84","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00198-019-04949-0","volume":"30","author":"A Mott","year":"2019","unstructured":"Mott A et al (2019) Effect of vitamin K on bone mineral density and fractures in adults: An updated systematic review and meta-analysis of randomised controlled trials. Osteoporos Int 30:1543\u20131559","journal-title":"Osteoporos Int"},{"key":"5033_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.maturitas.2020.05.020","volume":"140","author":"A Capozzi","year":"2020","unstructured":"Capozzi A, Scambia G, Lello S (2020) Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health. Maturitas 140:55\u201363","journal-title":"Maturitas"},{"key":"5033_CR86","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/jpn.13458","volume":"105","author":"R Omelka","year":"2021","unstructured":"Omelka R et al (2021) The effects of eggshell calcium (Biomin H) and its combinations with alfacalcidol (1\u03b1-hydroxyvitamin D3) and menaquinone-7 (vitamin K2) on ovariectomy-induced bone loss in a rat model of osteoporosis. J Anim Physiol Anim Nutr 105:336\u2013344","journal-title":"J Anim Physiol Anim Nutr"},{"key":"5033_CR87","doi-asserted-by":"publisher","first-page":"e12735","DOI":"10.1111\/cpr.12735","volume":"53","author":"M Bao","year":"2020","unstructured":"Bao M et al (2020) Therapeutic potentials and modulatory mechanisms of fatty acids in bone. Cell Prolif 53:e12735","journal-title":"Cell Prolif"},{"key":"5033_CR88","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.plipres.2010.06.002","volume":"49","author":"MC Kruger","year":"2010","unstructured":"Kruger MC, Coetzee M, Haag M, Weiler H (2010) Long-chain polyunsaturated fatty acids: Selected mechanisms of action on bone. Prog Lipid Res 49:438\u2013449","journal-title":"Prog Lipid Res"},{"key":"5033_CR89","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1359\/jbmr.2003.18.7.1206","volume":"18","author":"D Sun","year":"2003","unstructured":"Sun D et al (2003) Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18:1206\u20131216","journal-title":"J Bone Miner Res"},{"key":"5033_CR90","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jnutbio.2005.05.012","volume":"17","author":"BA Watkins","year":"2006","unstructured":"Watkins BA, Li Y, Seifert MF (2006) Dietary ratio of n-6\/n-3 PUFAs and docosahexaenoic acid: Actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem 17:282\u2013289","journal-title":"J Nutr Biochem"},{"key":"5033_CR91","doi-asserted-by":"publisher","first-page":"10562","DOI":"10.1021\/acs.jafc.1c03228","volume":"69","author":"T Zhang","year":"2021","unstructured":"Zhang T et al (2021) Comparative study of DHA with different molecular forms for ameliorating osteoporosis by promoting chondrocyte-to-osteoblast transdifferentiation in the growth plate of ovariectomized mice. J Agric Food Chem 69:10562\u201310571","journal-title":"J Agric Food Chem"},{"key":"5033_CR92","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11745-997-0036-x","volume":"32","author":"TG Atkinson","year":"1997","unstructured":"Atkinson TG, Barker HJ, Meckling-Gill KA (1997) Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats. Lipids 32:293\u2013302","journal-title":"Lipids"},{"key":"5033_CR93","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00223-019-00584-3","volume":"105","author":"A Abdelhamid","year":"2019","unstructured":"Abdelhamid A et al (2019) The relationship between omega-3, omega-6 and total polyunsaturated fat and musculoskeletal health and functional status in adults: A systematic review and meta-analysis of RCTs. Calcif Tissue Int 105:353\u2013372","journal-title":"Calcif Tissue Int"},{"key":"5033_CR94","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/fsn3.2655","volume":"10","author":"Y Dou","year":"2022","unstructured":"Dou Y, Wang Y, Chen Z, Yu X, Ma D (2022) Effect of n-3 polyunsaturated fatty acid on bone health: A systematic review and meta-analysis of randomized controlled trials. Food Sci Nutr 10:145\u2013154","journal-title":"Food Sci Nutr"},{"key":"5033_CR95","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/j.ddtec.2012.11.002","volume":"10","author":"EF Nemeth","year":"2013","unstructured":"Nemeth EF (2013) Allosteric modulators of the extracellular calcium receptor. Drug Discov Today Technol 10:e277\u2013e284","journal-title":"Drug Discov Today Technol"},{"key":"5033_CR96","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.beem.2013.02.008","volume":"27","author":"EF Nemeth","year":"2013","unstructured":"Nemeth EF, Shoback D (2013) Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders. Best Pract Res Clin Endocrinol Metab 27:373\u2013384","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5033_CR97","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1138\/20080318","volume":"5","author":"EF Nemeth","year":"2008","unstructured":"Nemeth EF (2008) Anabolic therapy for osteoporosis: Calcilytics. IBMS BoneKey 5:196\u2013208","journal-title":"IBMS BoneKey"},{"key":"5033_CR98","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/bph.15024","volume":"178","author":"BL Langdahl","year":"2021","unstructured":"Langdahl BL (2021) Overview of treatment approaches to osteoporosis. Br J Pharmacol 178:1891\u20131906","journal-title":"Br J Pharmacol"},{"key":"5033_CR99","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women\u2019s Health Initiative Investigators","year":"2002","unstructured":"Writing Group for the Women\u2019s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women\u2019s health initiative randomized controlled trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"5033_CR100","first-page":"139","volume":"20","author":"K Shigehara","year":"2017","unstructured":"Shigehara K et al (2017) Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: A subanalysis of a prospective randomized controlled study in Japan (EARTH study). Aging Male 20:139\u2013145","journal-title":"Aging Male"},{"key":"5033_CR101","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41569-019-0211-4","volume":"16","author":"T Gagliano-Juc\u00e1","year":"2019","unstructured":"Gagliano-Juc\u00e1 T, Basaria S (2019) Testosterone replacement therapy and cardiovascular risk. Nat Rev Cardiol 16:555\u2013574","journal-title":"Nat Rev Cardiol"},{"key":"5033_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/path.1711360104","volume":"136","author":"TJ Chambers","year":"1982","unstructured":"Chambers TJ, Magnus CJ (1982) Calcitonin alters behaviour of isolated osteoclasts. J Pathol 136:27\u201339","journal-title":"J Pathol"},{"key":"5033_CR103","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00198-007-0490-1","volume":"19","author":"CH Chesnut","year":"2008","unstructured":"Chesnut CH et al (2008) Salmon calcitonin: A review of current and future therapeutic indications. Osteoporos Int 19:479\u2013491","journal-title":"Osteoporos Int"},{"key":"5033_CR104","unstructured":"European Medicines Agency (EMA). Calcitonin approval status (2012). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/calcitonin."},{"key":"5033_CR105","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1080\/14756366.2018.1465417","volume":"33","author":"J Lu","year":"2018","unstructured":"Lu J et al (2018) Advances in the discovery of cathepsin K inhibitors on bone resorption. J Enzyme Inhib Med Chem 33:890\u2013904","journal-title":"J Enzyme Inhib Med Chem"},{"key":"5033_CR106","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1210\/jc.2012-2972","volume":"98","author":"K Brixen","year":"2013","unstructured":"Brixen K et al (2013) Bone density, turnover, and estimated strength in postmenopausal women treated with Odanacatib: A randomized trial. J Clin Endocrinol Metab 98:571\u2013580","journal-title":"J Clin Endocrinol Metab"},{"key":"5033_CR107","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jbmr.212","volume":"26","author":"JA Eisman","year":"2011","unstructured":"Eisman JA et al (2011) Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect. J Bone Miner Res 26:242\u2013251","journal-title":"J Bone Miner Res"},{"key":"5033_CR108","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","volume":"7","author":"MR McClung","year":"2019","unstructured":"McClung MR et al (2019) Odanacatib for the treatment of postmenopausal osteoporosis: Results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. Lancet Diabetes Endocrinol 7:899\u2013911","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5033_CR109","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.amjmed.2018.04.028","volume":"131","author":"I Kravets","year":"2018","unstructured":"Kravets I (2018) Paget\u2019s disease of bone: Diagnosis and treatment. Am J Med 131:1298\u20131303","journal-title":"Am J Med"},{"key":"5033_CR110","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.2165\/00003495-200666170-00004","volume":"66","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P (2006) Current pharmacological options for the management of primary hyperparathyroidism. Drugs 66:2189\u20132211","journal-title":"Drugs"},{"key":"5033_CR111","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032\u20131045","journal-title":"Mayo Clin Proc"},{"key":"5033_CR112","unstructured":"European Medicine Agengy (EMA). EMA. Denosumab. https:\/\/www.ema.europa.eu\/en\/search\/search?search_api_views_fulltext=denosumab (2023)."},{"key":"5033_CR113","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mjafi.2014.02.001","volume":"71","author":"N Dahiya","year":"2015","unstructured":"Dahiya N et al (2015) Denosumab: A bone antiresorptive drug. Med J Armed Forces India 71:71\u201375","journal-title":"Med J Armed Forces India"},{"key":"5033_CR114","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41584-019-0172-3","volume":"15","author":"E Seeman","year":"2019","unstructured":"Seeman E, Martin TJ (2019) Antiresorptive and anabolic agents in the prevention and reversal of bone fragility. Nat Rev Rheumatol 15:225\u2013236","journal-title":"Nat Rev Rheumatol"},{"key":"5033_CR115","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.bone.2012.01.020","volume":"50","author":"P Schwarz","year":"2012","unstructured":"Schwarz P, Rasmussen AQ, Kvist TM, Andersen UB, J\u00f8rgensen NR (2012) Paget\u2019s disease of the bone after treatment with Denosumab: A case report. Bone 50:1023\u20131025","journal-title":"Bone"},{"key":"5033_CR116","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1210\/jc.2013-3762","volume":"99","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA et al (2014) Denosumab treatment for juvenile Paget\u2019s disease: Results from two adult patients with osteoprotegerin deficiency (\u201cBalkan\u201d mutation in the TNFRSF11B gene). J Clin Endocrinol Metab 99:703\u2013707","journal-title":"J Clin Endocrinol Metab"},{"key":"5033_CR117","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jgs.15250","volume":"66","author":"C Eller-Vainicher","year":"2018","unstructured":"Eller-Vainicher C et al (2018) Protective effect of Denosumab on bone in older women with primary hyperparathyroidism. J Am Geriatr Soc 66:518\u2013524","journal-title":"J Am Geriatr Soc"},{"key":"5033_CR118","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/bcp.13759","volume":"85","author":"MK Skj\u00f8dt","year":"2019","unstructured":"Skj\u00f8dt MK, Frost M, Abrahamsen B (2019) Side effects of drugs for osteoporosis and metastatic bone disease. Br J Clin Pharmacol 85:1063\u20131071","journal-title":"Br J Clin Pharmacol"},{"key":"5033_CR119","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1210\/clinem\/dgz322","volume":"105","author":"T Diker-Cohen","year":"2020","unstructured":"Diker-Cohen T et al (2020) Risk for infections during treatment with Denosumab for osteoporosis: A systematic review and meta-analysis. J Clin Endocrinol Metab 105:1641\u20131658","journal-title":"J Clin Endocrinol Metab"},{"key":"5033_CR120","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00198-017-4242-6","volume":"29","author":"MB Zanchetta","year":"2018","unstructured":"Zanchetta MB et al (2018) Significant bone loss after stopping long-term denosumab treatment: A post FREEDOM study. Osteoporos Int 29:41\u201347","journal-title":"Osteoporos Int"},{"key":"5033_CR121","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00223-008-9180-z","volume":"83","author":"JS Hwang","year":"2008","unstructured":"Hwang JS et al (2008) The effects of strontium ranelate in Asian women with postmenopausal osteoporosis. Calcif Tissue Int 83:308\u2013314","journal-title":"Calcif Tissue Int"},{"key":"5033_CR122","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","volume":"5","author":"S Khosla","year":"2017","unstructured":"Khosla S, Hofbauer LC (2017) Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol 5:898\u2013907","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5033_CR123","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0140-6736(76)92216-9","volume":"307","author":"J Reeve","year":"1976","unstructured":"Reeve J et al (1976) Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. The Lancet 307:1035\u20131038","journal-title":"The Lancet"},{"key":"5033_CR124","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1210\/endo-123-1-187","volume":"123","author":"MF Rouleau","year":"1988","unstructured":"Rouleau MF, Mitchell J, Goltzman D (1988) In vivo distribution of parathyroid hormone receptors in bone: Evidence that a predominant osseous target cell is not the mature osteoblast. Endocrinology 123:187\u2013191","journal-title":"Endocrinology"},{"key":"5033_CR125","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/jbmr.5650111003","volume":"11","author":"Y Isogai","year":"1996","unstructured":"Isogai Y et al (1996) Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 11:1384\u20131393","journal-title":"J Bone Miner Res"},{"key":"5033_CR126","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11010-011-0856-8","volume":"355","author":"Y Tian","year":"2011","unstructured":"Tian Y, Xu Y, Fu Q, He M (2011) Parathyroid hormone regulates osteoblast differentiation in a Wnt\/\u03b2-catenin-dependent manner. Mol Cell Biochem 355:211\u2013216","journal-title":"Mol Cell Biochem"},{"key":"5033_CR127","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11914-008-0013-9","volume":"6","author":"S Kousteni","year":"2008","unstructured":"Kousteni S, Bilezikian JP (2008) The cell biology of parathyroid hormone in osteoblasts. Curr Osteoporos Rep 6:72\u201376","journal-title":"Curr Osteoporos Rep"},{"key":"5033_CR128","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","volume":"40","author":"RL Jilka","year":"2007","unstructured":"Jilka RL (2007) Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434\u20131446","journal-title":"Bone"},{"key":"5033_CR129","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cellsig.2009.02.012","volume":"21","author":"NS Datta","year":"2009","unstructured":"Datta NS, Abou-Samra AB (2009) PTH and PTHrP signaling in osteoblasts. Cell Signal 21:1245\u20131254","journal-title":"Cell Signal"},{"key":"5033_CR130","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1210\/js.2018-00118","volume":"2","author":"AV Haas","year":"2018","unstructured":"Haas AV, LeBoff MS (2018) Osteoanabolic agents for osteoporosis. J Endocr Soc 2:922\u2013932","journal-title":"J Endocr Soc"},{"key":"5033_CR131","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1172\/JCI71101","volume":"124","author":"ES Orwoll","year":"2014","unstructured":"Orwoll ES et al (2014) Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J Clin Invest 124:491\u2013498","journal-title":"J Clin Invest"},{"key":"5033_CR132","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/bcp.13766","volume":"85","author":"G Tabacco","year":"2019","unstructured":"Tabacco G, Bilezikian JP (2019) Osteoanabolic and dual action drugs. Br J Clin Pharmacol 85:1084\u20131094","journal-title":"Br J Clin Pharmacol"},{"key":"5033_CR133","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.yrtph.2017.04.001","volume":"86","author":"J Jolette","year":"2017","unstructured":"Jolette J et al (2017) Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1\u201334). Regul Toxicol Pharmacol 86:356\u2013365","journal-title":"Regul Toxicol Pharmacol"},{"key":"5033_CR134","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jbmr.4188","volume":"36","author":"A Gilsenan","year":"2021","unstructured":"Gilsenan A et al (2021) Teriparatide did not increase adult osteosarcoma incidence in a 15-year US postmarketing surveillance study. J Bone Miner Res 36:244\u2013251","journal-title":"J Bone Miner Res"},{"key":"5033_CR135","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/14656566.2020.1717468","volume":"21","author":"AD Anastasilakis","year":"2020","unstructured":"Anastasilakis AD, Polyzos SA, Yavropoulou MP, Makras P (2020) Combination and sequential treatment in women with postmenopausal osteoporosis. Expert Opin Pharmacother 21:477\u2013490","journal-title":"Expert Opin Pharmacother"},{"key":"5033_CR136","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00198-018-4790-4","volume":"30","author":"S Lou","year":"2019","unstructured":"Lou S et al (2019) Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 30:59\u201370","journal-title":"Osteoporos Int"},{"key":"5033_CR137","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00018-016-2425-5","volume":"74","author":"CM Karner","year":"2017","unstructured":"Karner CM, Long F (2017) Wnt signaling and cellular metabolism in osteoblasts. Cell Mol Life Sci 74:1649\u20131657","journal-title":"Cell Mol Life Sci"},{"key":"5033_CR138","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/8755122520967632","volume":"37","author":"SA Miller","year":"2021","unstructured":"Miller SA, St Onge EL, Whalen KL (2021) Romosozumab: A novel agent in the treatment for postmenopausal osteoporosis. J Pharm Technol 37:45\u201352","journal-title":"J Pharm Technol"},{"key":"5033_CR139","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/14728222.2020.1726889","volume":"24","author":"L Gennari","year":"2020","unstructured":"Gennari L et al (2020) Emerging therapeutic targets for osteoporosis. Expert Opin Ther Targets 24:115\u2013130","journal-title":"Expert Opin Ther Targets"},{"key":"5033_CR140","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.3390\/ijms23094748","volume":"23","author":"JM Sojan","year":"2022","unstructured":"Sojan JM, Raman R, Muller M, Carnevali O, Renn J (2022) Probiotics enhance bone growth and rescue BMP inhibition: New transgenic zebrafish lines to study bone health. Int J Mol Sci 23:4748","journal-title":"Int J Mol Sci"},{"key":"5033_CR141","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/biology11101402","volume":"11","author":"N Zemanova","year":"2022","unstructured":"Zemanova N, Omelka R, Mondockova V, Kovacova V, Martiniakova M (2022) Roles of gut microbiome in bone homeostasis and its relationship with bone-related diseases. Biology 11:1402","journal-title":"Biology"},{"key":"5033_CR142","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fendo.2020.00386","volume":"11","author":"M Maruyama","year":"2020","unstructured":"Maruyama M et al (2020) Modulation of the inflammatory response and bone healing. Front Endocrinol 11:386","journal-title":"Front Endocrinol"},{"key":"5033_CR143","doi-asserted-by":"publisher","first-page":"209","DOI":"10.11138\/ccmbm\/2017.14.1.209","volume":"14","author":"V Domazetovic","year":"2017","unstructured":"Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT (2017) Oxidative stress in bone remodeling: Role of antioxidants. Clin Cases Miner Bone Metab 14:209\u2013216","journal-title":"Clin Cases Miner Bone Metab"},{"key":"5033_CR144","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","volume":"19","author":"M Tsukasaki","year":"2019","unstructured":"Tsukasaki M, Takayanagi H (2019) Osteoimmunology: Evolving concepts in bone\u2013immune interactions in health and disease. Nat Rev Immunol 19:626\u2013642","journal-title":"Nat Rev Immunol"},{"key":"5033_CR145","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1002\/ctm2.368","volume":"11","author":"YJ Ko","year":"2021","unstructured":"Ko YJ et al (2021) A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor. Clin Transl Med 11:e368","journal-title":"Clin Transl Med"},{"key":"5033_CR146","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.omtm.2020.04.010","volume":"17","author":"Y-S Yang","year":"2020","unstructured":"Yang Y-S et al (2020) Bone-targeting AAV-mediated gene silencing in osteoclasts for osteoporosis therapy. Mol Ther-Methods Clin Dev 17:922\u2013935","journal-title":"Mol Ther-Methods Clin Dev"},{"key":"5033_CR147","doi-asserted-by":"publisher","first-page":"122755","DOI":"10.1016\/j.ijpharm.2023.122755","volume":"635","author":"T-Y Han","year":"2023","unstructured":"Han T-Y et al (2023) Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer. Int J Pharm 635:122755","journal-title":"Int J Pharm"},{"key":"5033_CR148","doi-asserted-by":"publisher","first-page":"e12956","DOI":"10.1111\/cpr.12956","volume":"54","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Zhang P, Zhang X, Lv L, Zhou Y (2021) Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell Prolif 54:e12956","journal-title":"Cell Prolif"},{"key":"5033_CR149","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.3390\/ijms222312750","volume":"22","author":"C-H Lu","year":"2021","unstructured":"Lu C-H, Chen Y-A, Ke C-C, Liu R-S (2021) Mesenchymal stem cell-derived extracellular vesicle: A promising alternative therapy for osteoporosis. Int J Mol Sci 22:12750","journal-title":"Int J Mol Sci"},{"key":"5033_CR150","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pcl.2009.11.006","volume":"57","author":"CG Steward","year":"2010","unstructured":"Steward CG (2010) Hematopoietic stem cell transplantation for osteopetrosis. Pediatr Clin North Am 57:171\u2013180","journal-title":"Pediatr Clin North Am"},{"key":"5033_CR151","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/bloodadvances.2018025890","volume":"3","author":"P Stepensky","year":"2019","unstructured":"Stepensky P et al (2019) Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years. Blood Adv 3:862\u2013868","journal-title":"Blood Adv"},{"key":"5033_CR152","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41409-020-01040-9","volume":"56","author":"E Even-Or","year":"2021","unstructured":"Even-Or E et al (2021) Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases. Bone Marrow Transplant 56:434\u2013441","journal-title":"Bone Marrow Transplant"},{"key":"5033_CR153","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1089\/hum.2019.047","volume":"30","author":"H L\u00f6fvall","year":"2019","unstructured":"L\u00f6fvall H (2019) Hematopoietic stem cell-targeted neonatal gene therapy with a clinically applicable lentiviral vector corrects osteopetrosis in oc\/oc mice. Hum Gene Ther 30:1395\u20131404","journal-title":"Hum Gene Ther"},{"key":"5033_CR154","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.cell.2015.11.031","volume":"163","author":"B Shen","year":"2015","unstructured":"Shen B (2015) A New Golden age of natural products drug discovery. Cell 163:1297\u20131300","journal-title":"Cell"},{"key":"5033_CR155","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/17460441.2019.1582639","volume":"14","author":"F Li","year":"2019","unstructured":"Li F, Wang Y, Li D, Chen Y, Dou QP (2019) Are we seeing a resurgence in the use of natural products for new drug discovery? Expert Opin Drug Discov 14:417\u2013420","journal-title":"Expert Opin Drug Discov"},{"key":"5033_CR156","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83:770\u2013803","journal-title":"J Nat Prod"},{"key":"5033_CR157","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/md13010202","volume":"13","author":"Y Hu","year":"2015","unstructured":"Hu Y et al (2015) Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012. Mar Drugs 13:202\u2013221","journal-title":"Mar Drugs"},{"key":"5033_CR158","doi-asserted-by":"publisher","first-page":"e20190105","DOI":"10.1590\/0001-3765201920190105","volume":"91","author":"JB Calixto","year":"2019","unstructured":"Calixto JB (2019) The role of natural products in modern drug discovery. An Acad Bras Cienc 91:e20190105","journal-title":"An Acad Bras Cienc"},{"key":"5033_CR159","first-page":"307","volume":"71","author":"M Martiniakova","year":"2020","unstructured":"Martiniakova M, Babikova M, Omelka R (2020) Pharmacological agents and natural compounds: Available treatments for osteoporosis. J Physiol Pharmacol 71:307\u2013320","journal-title":"J Physiol Pharmacol"},{"key":"5033_CR160","doi-asserted-by":"publisher","first-page":"6345857","DOI":"10.1155\/2018\/6345857","volume":"2018","author":"H Zhao","year":"2018","unstructured":"Zhao H et al (2018) Prevention and treatment of osteoporosis using chinese medicinal plants: Special emphasis on mechanisms of immune modulation. J Immunol Res 2018:6345857","journal-title":"J Immunol Res"},{"key":"5033_CR161","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1039\/C6NP00124F","volume":"34","author":"W Blunt","year":"2017","unstructured":"Blunt W, Copp JR, Keyzers BA, Munro RG, Prinsep MHMR (2017) Marine natural products. Nat Prod Rep 34:235\u2013294","journal-title":"Nat Prod Rep"},{"key":"5033_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bionut.2013.12.005","volume":"4","author":"K Senthilkumar","year":"2014","unstructured":"Senthilkumar K, Venkatesan J, Kim S-K (2014) Marine derived natural products for osteoporosis. Biomed Prev Nutr 4:1\u20137","journal-title":"Biomed Prev Nutr"},{"key":"5033_CR163","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1533\/9780857099037.3.294","volume-title":"Bone Substitute Biomaterials","author":"SA Clarke","year":"2014","unstructured":"Clarke SA, Walsh P (2014) Marine organisms for bone repair and regeneration. In: Mallick K (ed) Bone Substitute Biomaterials. Woodhead Publishing, UK, pp 294\u2013318"},{"key":"5033_CR164","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.biotechadv.2011.04.003","volume":"29","author":"SA Clarke","year":"2011","unstructured":"Clarke SA, Walsh P, Maggs CA, Buchanan F (2011) Designs from the deep: Marine organisms for bone tissue engineering. Biotechnol Adv 29:610\u2013617","journal-title":"Biotechnol Adv"},{"key":"5033_CR165","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21608\/adjc.2022.94504.1133","volume":"5","author":"M John","year":"2023","unstructured":"John M, Sugunan A, Aswathy S, Revu DS (2023) Marine based biomaterials: A Marvel in periodontal regeneration \u2013 A Review. Adv Dent J 5:24\u201334","journal-title":"Adv Dent J"},{"key":"5033_CR166","doi-asserted-by":"publisher","first-page":"213580","DOI":"10.1016\/j.bioadv.2023.213580","volume":"154","author":"Z Wang","year":"2023","unstructured":"Wang Z et al (2023) Current application and modification strategy of marine polysaccharides in tissue regeneration: A review. Biomater Adv 154:213580","journal-title":"Biomater Adv"},{"key":"5033_CR167","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1182\/blood-2007-04-084996","volume":"110","author":"KS Ahn","year":"2007","unstructured":"Ahn KS et al (2007) Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-\u03baB\u2013regulated gene products. Blood 110:2286\u20132295","journal-title":"Blood"},{"key":"5033_CR168","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/jcb.23213","volume":"113","author":"T Yonezawa","year":"2012","unstructured":"Yonezawa T et al (2012) Biselyngbyaside, isolated from marine cyanobacteria, inhibits osteoclastogenesis and induces apoptosis in mature osteoclasts. J Cell Biochem 113:440\u2013448","journal-title":"J Cell Biochem"},{"key":"5033_CR169","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1021\/acs.jnatprod.0c00042","volume":"83","author":"A Yamano","year":"2020","unstructured":"Yamano A et al (2020) Irijimasides A-E, macrolide glycosides from an Okeania sp. marine cyanobacterium. J Nat Prod 83:1585\u20131591","journal-title":"J Nat Prod"},{"key":"5033_CR170","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejphar.2015.11.003","volume":"769","author":"M Sapkota","year":"2015","unstructured":"Sapkota M, Li L, Choi H, Gerwick WH, Soh Y (2015) Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways. Eur J Pharmacol 769:100\u2013109","journal-title":"Eur J Pharmacol"},{"key":"5033_CR171","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.3390\/ijms22052303","volume":"22","author":"L Li","year":"2021","unstructured":"Li L et al (2021) Kalkitoxin reduces osteoclast formation and resorption and protects against inflammatory bone loss. Int J Mol Sci 22:2303","journal-title":"Int J Mol Sci"},{"key":"5033_CR172","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1021\/ja049277f","volume":"126","author":"M Kita","year":"2004","unstructured":"Kita M et al (2004) Symbioimine exhibiting inhibitory effect of osteoclast differentiation, from the symbiotic marine dinoflagellate Symbiodinium sp. J Am Chem Soc 126:4794\u20134795","journal-title":"J Am Chem Soc"},{"key":"5033_CR173","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s10126-022-10136-w","volume":"24","author":"SC Kim","year":"2022","unstructured":"Kim SC et al (2022) Sulfated glucuronorhamnoxylan from Capsosiphon fulvescens ameliorates osteoporotic bone resorption via inhibition of osteoclastic cell differentiation and function in vitro and in vivo. Mar Biotechnol 24:690\u2013705","journal-title":"Mar Biotechnol"},{"key":"5033_CR174","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1021\/jf100303k","volume":"58","author":"SK Das","year":"2010","unstructured":"Das SK, Ren R, Hashimoto T, Kanazawa K (2010) Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cells. J Agric Food Chem 58:6090\u20136095","journal-title":"J Agric Food Chem"},{"key":"5033_CR175","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/md19030132","volume":"19","author":"Y-J Ha","year":"2021","unstructured":"Ha Y-J et al (2021) Fucoxanthin suppresses osteoclastogenesis via modulation of MAP kinase and Nrf2 signaling. Mar Drugs 19:132","journal-title":"Mar Drugs"},{"key":"5033_CR176","first-page":"242","volume":"16","author":"L Guo","year":"2020","unstructured":"Guo L et al (2020) Protective effect of fucoxanthin on ovariectomy-induced osteoporosis in rats. Pharmacogn Mag 16:242\u2013249","journal-title":"Pharmacogn Mag"},{"key":"5033_CR177","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.bbrc.2013.04.046","volume":"434","author":"W-J Yoon","year":"2013","unstructured":"Yoon W-J et al (2013) Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-\u03baB and MAPKs in RANKL-induced RAW 264.7 cells. Biochem Biophys Res Commun 434:892\u2013897","journal-title":"Biochem Biophys Res Commun"},{"key":"5033_CR178","doi-asserted-by":"publisher","first-page":"112057","DOI":"10.1016\/j.exger.2022.112057","volume":"172","author":"W Jin","year":"2023","unstructured":"Jin W, Chen F, Fang Q, Mao G, Bao Y (2023) Oligosaccharides from Sargassum thunbergii inhibit osteoclast differentiation via regulation of IRF-8 signaling. Exp Gerontol 172:112057","journal-title":"Exp Gerontol"},{"key":"5033_CR179","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00253-012-4146-5","volume":"97","author":"J Zhu","year":"2013","unstructured":"Zhu J et al (2013) Mycoepoxydiene suppresses RANKL-induced osteoclast differentiation and reduces ovariectomy-induced bone loss in mice. Appl Microbiol Biotechnol 97:767\u2013774","journal-title":"Appl Microbiol Biotechnol"},{"key":"5033_CR180","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1021\/acs.jnatprod.6b00641","volume":"79","author":"JW Kim","year":"2016","unstructured":"Kim JW et al (2016) Stachybotrysin, an osteoclast differentiation inhibitor from the marine-derived fungus Stachybotrys sp. KCB13F013. J Nat. Prod 79:2703\u20132708","journal-title":"J Nat. Prod"},{"key":"5033_CR181","doi-asserted-by":"publisher","first-page":"e1800358","DOI":"10.1002\/cbdv.201800358","volume":"15","author":"J Wang","year":"2018","unstructured":"Wang J et al (2018) Osteoclastogenesis inhibitory polyketides from the sponge-associated fungus Xylaria feejeensis. Chem Biodivers 15:e1800358","journal-title":"Chem Biodivers"},{"key":"5033_CR182","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1021\/acs.jnatprod.8b01053","volume":"82","author":"D-H Liu","year":"2019","unstructured":"Liu D-H et al (2019) Osteoclastogenesis regulation metabolites from the coral-associated fungus Pseudallescheria boydii TW-1024-3. J Nat Prod 82:1274\u20131282","journal-title":"J Nat Prod"},{"key":"5033_CR183","doi-asserted-by":"publisher","first-page":"e202300551","DOI":"10.1002\/cbdv.202300551","volume":"20","author":"Y Hu","year":"2023","unstructured":"Hu Y et al (2023) New meroterpenoids and anti-osteoclastogenic polyketides from the mangrove-derived fungus Arthrinium sp. SCSIO 41306. Chem Biodivers 20:e202300551","journal-title":"Chem Biodivers"},{"key":"5033_CR184","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1111\/bph.15179","volume":"177","author":"Y Tan","year":"2020","unstructured":"Tan Y et al (2020) A marine fungus-derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF-\u03baB ligand-induced osteoclastogenesis and inflammatory bone destruction. Br J Pharmacol 177:4242\u20134260","journal-title":"Br J Pharmacol"},{"key":"5033_CR185","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1016\/j.bmcl.2017.10.017","volume":"27","author":"H Kato","year":"2017","unstructured":"Kato H et al (2017) Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts. Bioorg Med Chem Lett 27:4975\u20134978","journal-title":"Bioorg Med Chem Lett"},{"key":"5033_CR186","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1021\/acs.jnatprod.9b00690","volume":"82","author":"W Wang","year":"2019","unstructured":"Wang W et al (2019) Austalides, Osteoclast differentiation inhibitors from a marine-derived strain of the Fungus Penicillium rudallense. J Nat Prod 82:3083\u20133088","journal-title":"J Nat Prod"},{"key":"5033_CR187","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/md20030178","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Anti-osteoclastogenic and antibacterial effects of chlorinated polyketides from the Beibu gulf coral-derived fungus Aspergillus unguis GXIMD 02505. Mar Drugs 20:178","journal-title":"Mar Drugs"},{"key":"5033_CR188","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1021\/acs.jnatprod.1c00486","volume":"84","author":"AHH El-Desoky","year":"2021","unstructured":"El-Desoky AHH et al (2021) Taichunins E-T, isopimarane diterpenes and a 20-nor-isopimarane, from Aspergillus taichungensis (IBT 19404): Structures and inhibitory effects on RANKL-induced formation of multinuclear osteoclasts. J Nat Prod 84:2475\u20132485","journal-title":"J Nat Prod"},{"key":"5033_CR189","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/md16010014","volume":"16","author":"HJ Shin","year":"2018","unstructured":"Shin HJ et al (2018) Suppression of RANKL-induced osteoclastogenesis by the metabolites from the marine fungus Aspergillus flocculosus isolated from a sponge Stylissa sp. Mar Drugs 16:14","journal-title":"Mar Drugs"},{"key":"5033_CR190","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1021\/acs.jnatprod.2c00865","volume":"86","author":"Y Song","year":"2023","unstructured":"Song Y et al (2023) Tanzawaic acid derivatives from the marine-derived Penicillium steckii as inhibitors of RANKL-induced osteoclastogenesis. J Nat Prod 86:1171\u20131178","journal-title":"J Nat Prod"},{"key":"5033_CR191","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.3390\/md12115643","volume":"12","author":"MR Kang","year":"2014","unstructured":"Kang MR et al (2014) Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-\u03baB. Mar Drugs 12:5643\u20135656","journal-title":"Mar Drugs"},{"key":"5033_CR192","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3390\/md12042054","volume":"12","author":"H Kim","year":"2014","unstructured":"Kim H et al (2014) Placotylene A, an inhibitor of the receptor activator of nuclear factor-\u03baB ligand-induced osteoclast differentiation, from a Korean sponge Placospongia sp. Mar Drugs 12:2054\u20132065","journal-title":"Mar Drugs"},{"key":"5033_CR193","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1016\/j.bmcl.2014.09.043","volume":"24","author":"S Tsukamoto","year":"2014","unstructured":"Tsukamoto S et al (2014) Halenaquinone inhibits RANKL-induced osteoclastogenesis. Bioorg Med Chem Lett 24:5315\u20135317","journal-title":"Bioorg Med Chem Lett"},{"key":"5033_CR194","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1021\/np010500l","volume":"65","author":"AD Patil","year":"2002","unstructured":"Patil AD et al (2002) Haploscleridamine, a novel tryptamine-derived alkaloid from a sponge of the order Haplosclerida: An inhibitor of cathepsin K. J Nat Prod 65:628\u2013629","journal-title":"J Nat Prod"},{"key":"5033_CR195","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1021\/acs.jnatprod.6b00158","volume":"79","author":"AH El-Desoky","year":"2016","unstructured":"El-Desoky AH et al (2016) Ceylonamides A-F, nitrogenous spongian diterpenes that inhibit RANKL-induced osteoclastogenesis, from the marine sponge Spongia ceylonensis. J Nat Prod 79:1922\u20131928","journal-title":"J Nat Prod"},{"key":"5033_CR196","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1021\/acs.jnatprod.6b00725","volume":"80","author":"AH El-Desoky","year":"2017","unstructured":"El-Desoky AH et al (2017) Ceylonins A-F, spongian diterpene derivatives that inhibit RANKL-induced formation of multinuclear osteoclasts, from the marine sponge Spongia ceylonensis. J Nat Prod 80:90\u201395","journal-title":"J Nat Prod"},{"key":"5033_CR197","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3987\/COM-18-S(T)73","volume":"97","author":"S Tsukamoto","year":"2018","unstructured":"Tsukamoto S et al (2018) Isolation of aaptic acid from the marine sponge Aaptos lobata and inhibitory effect of aaptamines on RANKL-induced formation of multinuclear osteoclasts. Heterocycles 97:1219\u20131225","journal-title":"Heterocycles"},{"key":"5033_CR198","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.fitote.2018.05.001","volume":"128","author":"AA El-Beih","year":"2018","unstructured":"El-Beih AA et al (2018) New inhibitors of RANKL-induced osteoclastogenesis from the marine sponge Siphonochalina siphonella. Fitoterapia 128:43\u201349","journal-title":"Fitoterapia"},{"key":"5033_CR199","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1021\/acs.jnatprod.1c00758","volume":"84","author":"Y Maeyama","year":"2021","unstructured":"Maeyama Y et al (2021) Amakusamine from a Psammocinia sp. sponge: Isolation, synthesis, and SAR study on the inhibition of RANKL-induced formation of multinuclear osteoclasts. J Nat Prod 84:2738\u20132743","journal-title":"J Nat Prod"},{"key":"5033_CR200","doi-asserted-by":"publisher","first-page":"113872","DOI":"10.1016\/j.phytochem.2023.113872","volume":"216","author":"AH El-Desoky","year":"2023","unstructured":"El-Desoky AH et al (2023) Aaptocarbamates A\u2212G, chlorinated terpene carbamates with antiosteoclastogenic activities from the marine sponge Aaptos sp. Phytochemistry 216:113872","journal-title":"Phytochemistry"},{"key":"5033_CR201","doi-asserted-by":"publisher","first-page":"e62926","DOI":"10.1371\/journal.pone.0062926","volume":"8","author":"Y-Y Lin","year":"2013","unstructured":"Lin Y-Y et al (2013) A soft coral-derived compound, 11-epi-sinulariolide acetate suppresses inflammatory response and bone destruction in adjuvant-induced arthritis. PLoS One 8:e62926","journal-title":"PLoS One"},{"key":"5033_CR202","doi-asserted-by":"publisher","first-page":"104976","DOI":"10.1016\/j.bioorg.2021.104976","volume":"112","author":"J Meng","year":"2021","unstructured":"Meng J et al (2021) Briarane-type diterpenoids suppress osteoclastogenisis by regulation of Nrf2 and MAPK\/NF-kB signaling pathway. Bioorganic Chem 112:104976","journal-title":"Bioorganic Chem"},{"key":"5033_CR203","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/md15010009","volume":"15","author":"Y-Y Lin","year":"2017","unstructured":"Lin Y-Y et al (2017) Excavatolide B attenuates rheumatoid arthritis through the inhibition of isteoclastogenesis. Mar Drugs 15:9","journal-title":"Mar Drugs"},{"key":"5033_CR204","doi-asserted-by":"publisher","first-page":"105201","DOI":"10.1016\/j.fitote.2022.105201","volume":"159","author":"H Lu","year":"2022","unstructured":"Lu H et al (2022) Osteoclastogenesis inhibitory phenolic derivatives produced by the Beibu Gulf coral-associated fungus Acremonium sclerotigenum GXIMD 02501. Fitoterapia 159:105201","journal-title":"Fitoterapia"},{"key":"5033_CR205","doi-asserted-by":"publisher","first-page":"e2000266","DOI":"10.1002\/cbdv.202000266","volume":"17","author":"C Xu","year":"2020","unstructured":"Xu C, Li J, Su L, Tang H, Zhang W (2020) Osteoclastogenesis modulatory steroids from the South China Sea gorgonian coral Iciligorgia sp. Chem Biodivers 17:e2000266","journal-title":"Chem Biodivers"},{"key":"5033_CR206","doi-asserted-by":"publisher","first-page":"114948","DOI":"10.1016\/j.ejmech.2022.114948","volume":"246","author":"X Qi","year":"2023","unstructured":"Qi X et al (2023) Briarane-type diterpenoids, the inhibitors of osteoclast formation by interrupting Keap1-Nrf2 interaction and activating Nrf2 pathway. Eur J Med Chem 246:114948","journal-title":"Eur J Med Chem"},{"key":"5033_CR207","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1271\/bbb.50644","volume":"70","author":"S Kazami","year":"2006","unstructured":"Kazami S et al (2006) Iejimalides show anti-osteoclast activity via V-ATPase inhibition. Biosci Biotechnol Biochem 70:1364\u20131370","journal-title":"Biosci Biotechnol Biochem"},{"key":"5033_CR208","doi-asserted-by":"publisher","first-page":"106756","DOI":"10.1016\/j.bioorg.2023.106756","volume":"139","author":"Z-H He","year":"2023","unstructured":"He Z-H et al (2023) Neotricitrinols A-C, unprecedented citrinin trimers with anti-osteoporosis activity from the deep-sea-derived Penicillium citrinum W23. Bioorganic Chem 139:106756","journal-title":"Bioorganic Chem"},{"key":"5033_CR209","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4429292","author":"C-L Xie","year":"2023","unstructured":"Xie C-L et al (2023) Deep-sea-derived Penicopeptide a (Ppa) promotes osteoblast-mediated bone formation and alleviates ovariectomy-induced bone loss by activating the Akt\/Gsk-3\u03b2\/\u0392-Catenin signaling pathway. SSRN Scholarly Paper at. https:\/\/doi.org\/10.2139\/ssrn.4429292","journal-title":"SSRN Scholarly Paper at"},{"key":"5033_CR210","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00726-011-0901-7","volume":"42","author":"SN Kim","year":"2012","unstructured":"Kim SN et al (2012) In vitro and in vivo osteogenic activity of licochalcone A. Amino Acids 42:1455\u20131465","journal-title":"Amino Acids"},{"key":"5033_CR211","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1021\/acs.jnatprod.0c00441","volume":"83","author":"N Natsume","year":"2020","unstructured":"Natsume N, Ozaki K, Nakajima D, Yokoshima S, Teruya T (2020) Structure\u2013activity relationship study of Majusculamides A and B and their analogues on osteogenic activity. J Nat Prod 83:2477\u20132482","journal-title":"J Nat Prod"},{"key":"5033_CR212","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1016\/j.tetlet.2014.04.086","volume":"55","author":"M Akakabe","year":"2014","unstructured":"Akakabe M et al (2014) Amphirionin-5, a novel linear polyketide from a cultured marine dinoflagellate Amphidinium species with a potent cell proliferation-promoting activity. Tetrahedron Lett 55:3491\u20133494","journal-title":"Tetrahedron Lett"},{"key":"5033_CR213","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jff.2015.09.022","volume":"19","author":"B Ryu","year":"2015","unstructured":"Ryu B, Li Y-X, Kang K-H, Kim S-K, Kim DG (2015) Floridoside from Laurencia undulata promotes osteogenic differentiation in murine bone marrow mesenchymal cells. J Funct Foods 19:505\u2013511","journal-title":"J Funct Foods"},{"key":"5033_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.lwt.2020.110437","volume":"137","author":"Y Chen","year":"2021","unstructured":"Chen Y et al (2021) Dunaliella salina-derived peptide protects from bone loss: Isolation, purification and identification. LWT 137:110437","journal-title":"LWT"},{"key":"5033_CR215","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.procbio.2013.06.031","volume":"48","author":"MHT Nguyen","year":"2013","unstructured":"Nguyen MHT et al (2013) Tetrameric peptide purified from hydrolysates of biodiesel byproducts of Nannochloropsis oculata induces osteoblastic differentiation through MAPK and Smad pathway on MG-63 and D1 cells. Process Biochem 48:1387\u20131394","journal-title":"Process Biochem"},{"key":"5033_CR216","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cbi.2009.01.006","volume":"179","author":"B Ryu","year":"2009","unstructured":"Ryu B, Li Y, Qian Z-J, Kim M-M, Kim S-K (2009) Differentiation of human osteosarcoma cells by isolated phlorotannins is subtly linked to COX-2, iNOS, MMPs, and MAPK signaling: Implication for chronic articular disease. Chem Biol Interact 179:192\u2013201","journal-title":"Chem Biol Interact"},{"key":"5033_CR217","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/md14090168","volume":"14","author":"B-N Ahn","year":"2016","unstructured":"Ahn B-N et al (2016) Dioxinodehydroeckol enhances the differentiation of osteoblasts by regulating the expression of phospho-Smad1\/5\/8. Mar Drugs 14:168","journal-title":"Mar Drugs"},{"key":"5033_CR218","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/jsfa.7148","volume":"96","author":"J-A Kim","year":"2016","unstructured":"Kim J-A et al (2016) Bioactive quinone derivatives from the marine brown alga Sargassum thunbergii induce anti-adipogenic and pro-osteoblastogenic activities. J Sci Food Agric 96:783\u2013790","journal-title":"J Sci Food Agric"},{"key":"5033_CR219","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/md17100543","volume":"17","author":"JH Oh","year":"2019","unstructured":"Oh JH et al (2019) Phlorofucofuroeckol A from edible brown alga Ecklonia Cava enhances osteoblastogenesis in bone marrow-derived human mesenchymal stem cells. Mar Drugs 17:543","journal-title":"Mar Drugs"},{"key":"5033_CR220","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.febslet.2012.03.008","volume":"586","author":"MR Byun","year":"2012","unstructured":"Byun MR et al (2012) Phorbaketal A stimulates osteoblast differentiation through TAZ mediated Runx2 activation. FEBS Lett 586:1086\u20131092","journal-title":"FEBS Lett"},{"key":"5033_CR221","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1021\/ol1029386","volume":"13","author":"JR Rho","year":"2011","unstructured":"Rho JR et al (2011) Phorbasones A and B, sesterterpenoids isolated from the marine sponge Phorbas sp. and induction of osteoblast differentiation. Org. Lett. 13:884\u2013887","journal-title":"Org. Lett."},{"key":"5033_CR222","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/md20020135","volume":"20","author":"M Carnovali","year":"2022","unstructured":"Carnovali M et al (2022) Aerophobin-1 from the marine sponge Aplysina aerophoba modulates osteogenesis in zebrafish larvae. Mar Drugs 20:135","journal-title":"Mar Drugs"},{"key":"5033_CR223","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00774-009-0049-7","volume":"27","author":"M Kinugawa","year":"2009","unstructured":"Kinugawa M, Fukuzawa S, Tachibana K (2009) Skeletal protein protection: The mode of action of an anti-osteoporotic marine alkaloid, norzoanthamine. J Bone Miner Metab 27:303\u2013314","journal-title":"J Bone Miner Metab"},{"key":"5033_CR224","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1248\/cpb.56.988","volume":"56","author":"NX Cuong","year":"2008","unstructured":"Cuong NX et al (2008) New cembranoid diterpenes from the Vietnamese soft coral Sarcophyton mililatensis stimulate osteoblastic differentiation in MC3T3-E1 cells. Chem Pharm Bull (Tokyo) 56:988\u2013992","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"5033_CR225","first-page":"1934578X0700201","volume":"2","author":"C Van Minh","year":"2007","unstructured":"Van Minh C et al (2007) A new 9,11-secosterol from the Vietnamese sea soft coral, Sarcophyton mililatensis, increases the function of osteoblastic MC3T3-E1 cells. Nat Prod Commun 2:1934578X070020109","journal-title":"Nat Prod Commun"},{"key":"5033_CR226","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/md18100510","volume":"18","author":"Y Oh","year":"2020","unstructured":"Oh Y, Ahn C-B, Je J-Y (2020) Blue mussel-derived peptides PIISVYWK and FSVVPSPK trigger Wnt\/\u03b2-Catenin signaling-mediated osteogenesis in human bone marrow mesenchymal stem cells. Mar Drugs 18:510","journal-title":"Mar Drugs"},{"key":"5033_CR227","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/antiox9090866","volume":"9","author":"Y Oh","year":"2020","unstructured":"Oh Y, Ahn C-B, Cho WH, Yoon NY, Je J-Y (2020) Anti-osteoporotic effects of antioxidant peptides PIISVYWK and FSVVPSPK from Mytilus edulis on ovariectomized mice. Antioxidants 9:866","journal-title":"Antioxidants"},{"key":"5033_CR228","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.foodchem.2018.07.063","volume":"272","author":"H Chen","year":"2019","unstructured":"Chen H et al (2019) Identification and mechanism evaluation of a novel osteogenesis promoting peptide from Tubulin Alpha-1C chain in Crassostrea gigas. Food Chem 272:751\u2013757","journal-title":"Food Chem"},{"key":"5033_CR229","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.4028\/www.scientific.net\/AMR.781-784.1260","volume":"781\u2013784","author":"J Guo","year":"2013","unstructured":"Guo J, Liao J, Li YP, Song WD, Liu JS (2013) Study on anti-osteoporosis of compound pearl protein polypeptide. Adv Mater Res 781\u2013784:1260\u20131264","journal-title":"Adv Mater Res"},{"key":"5033_CR230","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3390\/molecules23092302","volume":"23","author":"Z Jiang","year":"2018","unstructured":"Jiang Z et al (2018) Dietary natural N-acetyl-D-glucosamine prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis. Molecules 23:2302","journal-title":"Molecules"},{"key":"5033_CR231","doi-asserted-by":"publisher","first-page":"1173110","DOI":"10.3389\/fphar.2023.1173110","volume":"14","author":"P Wang","year":"2023","unstructured":"Wang P et al (2023) A synthetic peptide from Sipunculus nudus promotes bone formation via Estrogen\/MAPK signal pathway based on network pharmacology. Front Pharmacol 14:1173110","journal-title":"Front Pharmacol"},{"key":"5033_CR232","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1021\/acs.jafc.0c06466","volume":"69","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) Stichopus japonicus polysaccharide stimulates osteoblast differentiation through activation of the bone morphogenetic protein pathway in MC3T3-E1 cells. J Agric Food Chem 69:2576\u20132584","journal-title":"J Agric Food Chem"},{"key":"5033_CR233","doi-asserted-by":"publisher","first-page":"170686","DOI":"10.1016\/j.peptides.2021.170686","volume":"148","author":"Y-S Lee","year":"2022","unstructured":"Lee Y-S, Feng C-W, Peng M-Y, Chen Y-C, Chan T-F (2022) Antiosteoporosis effects of a marine antimicrobial peptide pardaxin via regulation of the osteogenesis pathway. Peptides 148:170686","journal-title":"Peptides"},{"key":"5033_CR234","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cbf.3325","volume":"36","author":"S-Y Heo","year":"2018","unstructured":"Heo S-Y et al (2018) Fish bone peptide promotes osteogenic differentiation of MC3T3-E1 pre-osteoblasts through upregulation of MAPKs and Smad pathways activated BMP-2 receptor. Cell Biochem Funct 36:137\u2013146","journal-title":"Cell Biochem Funct"},{"key":"5033_CR235","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ijbiomac.2019.12.189","volume":"145","author":"C Gavva","year":"2020","unstructured":"Gavva C, Patel K, Kudre T, Sharan K, Chilkunda DN (2020) Glycosaminoglycans from fresh water fish processing discard - Isolation, structural characterization, and osteogenic activity. Int J Biol Macromol 145:558\u2013567","journal-title":"Int J Biol Macromol"},{"key":"5033_CR236","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.procbio.2018.01.025","volume":"67","author":"V-T Nguyen","year":"2018","unstructured":"Nguyen V-T et al (2018) Ciona intestinalis calcitonin-like peptide promotes osteoblast differentiation and mineralization through MAPK pathway in MC3T3-E1 cells. Process Biochem 67:127\u2013138","journal-title":"Process Biochem"},{"key":"5033_CR237","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejphar.2017.09.015","volume":"815","author":"L Li","year":"2017","unstructured":"Li L, Sapkota M, Gao M, Choi H, Soh Y (2017) Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2\/smad\/Akt\/Runx2 signaling pathway. Eur J Pharmacol 815:202\u2013209","journal-title":"Eur J Pharmacol"},{"key":"5033_CR238","doi-asserted-by":"publisher","first-page":"173305","DOI":"10.1016\/j.ejphar.2020.173305","volume":"883","author":"M Sapkota","year":"2020","unstructured":"Sapkota M et al (2020) Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling. Eur J Pharmacol 883:173305","journal-title":"Eur J Pharmacol"},{"key":"5033_CR239","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3892\/mmr.2016.6062","volume":"15","author":"X Jin","year":"2017","unstructured":"Jin X et al (2017) Low-molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats. Mol Med Rep 15:890\u2013898","journal-title":"Mol Med Rep"},{"key":"5033_CR240","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.foodchem.2009.03.051","volume":"116","author":"Y-S Cho","year":"2009","unstructured":"Cho Y-S, Jung W-K, Kim J-A, Choi I-W, Kim S-K (2009) Beneficial effects of fucoidan on osteoblastic MG-63 cell differentiation. Food Chem 116:990\u2013994","journal-title":"Food Chem"},{"key":"5033_CR241","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/mnfr.201300319","volume":"58","author":"D-G Lee","year":"2014","unstructured":"Lee D-G et al (2014) The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis. Mol Nutr Food Res 58:1249\u20131257","journal-title":"Mol Nutr Food Res"},{"key":"5033_CR242","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3390\/ijms18122635","volume":"18","author":"HJ Ihn","year":"2017","unstructured":"Ihn HJ et al (2017) Diphlorethohydroxycarmalol from Ishige okamurae suppresses osteoclast differentiation by downregulating the NF-\u03baB signaling pathway. Int J Mol Sci 18:2635","journal-title":"Int J Mol Sci"},{"key":"5033_CR243","doi-asserted-by":"publisher","first-page":"104921","DOI":"10.1016\/j.fitote.2021.104921","volume":"152","author":"S-H Lee","year":"2021","unstructured":"Lee S-H, Kim M, Park MH (2021) Diphlorethohydroxycamalol isolated from Ishige okamurae prevents H2O2-induced oxidative damage via BMP2\/Runx2 signaling in osteoblastic MC3T3-E1 cells. Fitoterapia 152:104921","journal-title":"Fitoterapia"},{"key":"5033_CR244","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0254-6272(16)30046-2","volume":"36","author":"W Li","year":"2016","unstructured":"Li W, Haiya W, Ningyuan F (2016) Algal oligosaccharides ameliorate osteoporosis via up-regulation of parathyroid hormone 1\u201384 and vascular endothelial growth factor. J Tradit Chin Med 36:332\u2013339","journal-title":"J Tradit Chin Med"},{"key":"5033_CR245","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/md21070377","volume":"21","author":"S-H Cho","year":"2023","unstructured":"Cho S-H et al (2023) Effect of Ishophloroglucin A isolated from Ishige okamurae on in vitro osteoclastogenesis and osteoblastogenesis. Mar Drugs 21:377","journal-title":"Mar Drugs"},{"key":"5033_CR246","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/ijms19030912","volume":"19","author":"Y-H Hwang","year":"2018","unstructured":"Hwang Y-H et al (2018) Suppression effect of astaxanthin on osteoclast formation in vitro and bone loss in vivo. Int J Mol Sci 19:912","journal-title":"Int J Mol Sci"},{"key":"5033_CR247","first-page":"e3427430","volume":"2020","author":"G Zhao","year":"2020","unstructured":"Zhao G, Zhong H, Rao T, Pan Z (2020) Metabolomic analysis reveals that the mechanism of astaxanthin improves the osteogenic differentiation potential in bone marrow mesenchymal stem cells. Oxid Med Cell Longev 2020:e3427430","journal-title":"Oxid Med Cell Longev"},{"key":"5033_CR248","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.3390\/ijms22115493","volume":"22","author":"K-J Kim","year":"2021","unstructured":"Kim K-J et al (2021) Austalide K from the fungus Penicillium rudallense prevents LPS-induced bone loss in mice by inhibiting osteoclast differentiation and promoting osteoblast differentiation. Int J Mol Sci 22:5493","journal-title":"Int J Mol Sci"},{"key":"5033_CR249","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/jbmr.4025","volume":"35","author":"Q Wang","year":"2020","unstructured":"Wang Q et al (2020) Hymenialdisine: A marine natural product that acts on both osteoblasts and osteoclasts and prevents estrogen-dependent bone loss in mice. J Bone Miner Res 35:1582\u20131596","journal-title":"J Bone Miner Res"},{"key":"5033_CR250","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1039\/C9FO01201J","volume":"10","author":"Z Xu","year":"2019","unstructured":"Xu Z et al (2019) Bone formation activity of an osteogenic dodecapeptide from blue mussels (Mytilus edulis). Food Funct 10:5616\u20135625","journal-title":"Food Funct"},{"key":"5033_CR251","doi-asserted-by":"publisher","first-page":"9961","DOI":"10.1021\/acs.jafc.0c02779","volume":"68","author":"Z Xu","year":"2020","unstructured":"Xu Z et al (2020) Pharmacokinetics and transport of an osteogenic dodecapeptide. J Agric Food Chem 68:9961\u20139967","journal-title":"J Agric Food Chem"},{"key":"5033_CR252","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/jsfa.11468","volume":"102","author":"J Song","year":"2022","unstructured":"Song J et al (2022) Positive effect of compound amino acid chelated calcium from the shell and skirt of scallop in an ovariectomized rat model of postmenopausal osteoporosis. J Sci Food Agric 102:1363\u20131371","journal-title":"J Sci Food Agric"},{"key":"5033_CR253","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/md17010051","volume":"17","author":"D-W Lee","year":"2019","unstructured":"Lee D-W et al (2019) The effect of polydeoxyribonucleotide extracted from salmon sperm on the restoration of bisphosphonate-related osteonecrosis of the jaw. Mar Drugs 17:51","journal-title":"Mar Drugs"},{"key":"5033_CR254","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/md19090484","volume":"19","author":"F Menaa","year":"2021","unstructured":"Menaa F et al (2021) Marine algae-derived bioactive compounds: A new wave of nanodrugs? Mar Drugs 19:484","journal-title":"Mar Drugs"},{"key":"5033_CR255","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00223-017-0299-7","volume":"101","author":"O Brennan","year":"2017","unstructured":"Brennan O et al (2017) A natural calcium-rich multi-mineral complex preserves bones structure, composition and strength in an ovariectomized rat model of osteoporosis. Calcif Tissue Int 101:445\u2013455","journal-title":"Calcif Tissue Int"},{"key":"5033_CR256","doi-asserted-by":"publisher","first-page":"7725","DOI":"10.1038\/s41598-018-26024-0","volume":"8","author":"MA Carson","year":"2018","unstructured":"Carson MA et al (2018) Red algal extracts from Plocamium lyngbyanum and Ceramium secundatum stimulate osteogenic activities in vitro and bone growth in zebrafish larvae. Sci Rep 8:7725","journal-title":"Sci Rep"},{"key":"5033_CR257","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/jpp\/rgaa046","volume":"73","author":"M Nekooei","year":"2021","unstructured":"Nekooei M, Shafiee SM, Zahiri M, Maryamabadi A, Nabipour I (2021) The methanol extract of red algae, Dichotomaria obtusata, from Persian Gulf promotes in vitro osteogenic differentiation of bone marrow mesenchymal stem cells: A biological and phytochemical study. J Pharm Pharmacol 73:347\u2013356","journal-title":"J Pharm Pharmacol"},{"key":"5033_CR258","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/md17080473","volume":"17","author":"M Minetti","year":"2019","unstructured":"Minetti M et al (2019) Padina pavonica extract promotes in vitro differentiation and functionality of human primary osteoblasts. Mar Drugs 17:473","journal-title":"Mar Drugs"},{"key":"5033_CR259","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1002\/jsfa.12031","volume":"102","author":"H Yu","year":"2022","unstructured":"Yu H, Chen Y, Zhu J (2022) Osteogenic activities of four calcium-chelating microalgae peptides. J Sci Food Agric 102:6643\u20136649","journal-title":"J Sci Food Agric"},{"key":"5033_CR260","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/molecules26040943","volume":"26","author":"V Balasubramaniam","year":"2021","unstructured":"Balasubramaniam V, Gunasegavan RD-N, Mustar S, Lee JC, Mohd Noh MF (2021) Isolation of industrial important bioactive compounds from microalgae. Molecules 26:943","journal-title":"Molecules"},{"key":"5033_CR261","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10811-020-02350-7","volume":"33","author":"Q Shi","year":"2021","unstructured":"Shi Q et al (2021) Transgenic eukaryotic microalgae as green factories: Providing new ideas for the production of biologically active substances. J Appl Phycol 33:705\u2013728","journal-title":"J Appl Phycol"},{"key":"5033_CR262","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00018-023-04953-y","volume":"80","author":"A Carletti","year":"2023","unstructured":"Carletti A et al (2023) The osteogenic and mineralogenic potential of the microalgae Skeletonema costatum and Tetraselmis striata CTP4 in fish models. Cell Mol Life Sci 80:310","journal-title":"Cell Mol Life Sci"},{"key":"5033_CR263","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.foodchem.2013.07.027","volume":"142","author":"U Grienke","year":"2014","unstructured":"Grienke U, Silke J, Tasdemir D (2014) Bioactive compounds from marine mussels and their effects on human health. Food Chem 142:48\u201360","journal-title":"Food Chem"},{"key":"5033_CR264","doi-asserted-by":"publisher","first-page":"267","DOI":"10.14348\/molcells.2015.2315","volume":"38","author":"DW Green","year":"2015","unstructured":"Green DW, Kwon H-J, Jung H-S (2015) Osteogenic potency of nacre on human mesenchymal stem cells. Mol Cells 38:267\u2013272","journal-title":"Mol Cells"},{"key":"5033_CR265","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1016\/j.biomaterials.2007.07.036","volume":"28","author":"D Duplat","year":"2007","unstructured":"Duplat D et al (2007) The effect of molecules in mother-of-pearl on the decrease in bone resorption through the inhibition of osteoclast cathepsin K. Biomaterials 28:4769\u20134778","journal-title":"Biomaterials"},{"key":"5033_CR266","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/biom9110711","volume":"9","author":"IMN Molagoda","year":"2019","unstructured":"Molagoda IMN et al (2019) Fermented oyster extract promotes osteoblast differentiation by activating the Wnt\/\u03b2-Catenin signaling pathway, leading to bone formation. Biomolecules 9:711","journal-title":"Biomolecules"},{"key":"5033_CR267","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/md18090472","volume":"18","author":"IMN Molagoda","year":"2020","unstructured":"Molagoda IMN et al (2020) Fermented oyster extract promotes insulin-like growth factor-1-mediated osteogenesis and growth Rate. Mar Drugs 18:472","journal-title":"Mar Drugs"},{"key":"5033_CR268","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/nu11061392","volume":"11","author":"HJ Ihn","year":"2019","unstructured":"Ihn HJ et al (2019) Fermented oyster extract prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis. Nutrients 11:1392","journal-title":"Nutrients"},{"key":"5033_CR269","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.3390\/ijms20236076","volume":"20","author":"MH Choi","year":"2019","unstructured":"Choi MH, Lee K, Kim MY, Shin H-I, Jeong D (2019) Pisidium coreanum inhibits multinucleated osteoclast formation and prevents estrogen-deficient osteoporosis. Int J Mol Sci 20:6076","journal-title":"Int J Mol Sci"},{"key":"5033_CR270","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fendo.2019.00608","volume":"10","author":"S Chaugule","year":"2019","unstructured":"Chaugule S et al (2019) Hexane fraction of Turbo brunneus inhibits intermediates of RANK-RANKL signaling pathway and prevent ovariectomy induced bone loss. Front Endocrinol 10:608","journal-title":"Front Endocrinol"},{"key":"5033_CR271","doi-asserted-by":"publisher","first-page":"e348189","DOI":"10.1155\/2014\/348189","volume":"2014","author":"B Balakrishnan","year":"2014","unstructured":"Balakrishnan B, Chiplunkar SV, Indap MM (2014) Methanol extract of Euchelus asper prevents bone resorption in ovariectomised mice model. J Osteoporos 2014:e348189","journal-title":"J Osteoporos"},{"key":"5033_CR272","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/md18070373","volume":"18","author":"Y Hou","year":"2020","unstructured":"Hou Y et al (2020) PHNQ from Evechinus chloroticus sea urchin supplemented with calcium promotes mineralization in SaOS-2 human bone cell line. Mar Drugs 18:373","journal-title":"Mar Drugs"},{"key":"5033_CR273","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5704\/MOJ.1303.015","volume":"7","author":"A Shahrulazua","year":"2013","unstructured":"Shahrulazua A, Samsudin A, Iskandar M, Amran A (2013) The in-vitro effects of sea cucumber (Stichopus sp1) extract on human osteoblast cell line. Malays Orthop J 7:41\u201348","journal-title":"Malays Orthop J"},{"key":"5033_CR274","doi-asserted-by":"publisher","first-page":"101572","DOI":"10.1016\/j.fbio.2022.101572","volume":"46","author":"Z Chen","year":"2022","unstructured":"Chen Z et al (2022) Sea cucumber enzymatic hydrolysates relieve osteoporosis through OPG\/RANK\/RANKL system in ovariectomized rats. Food Biosci 46:101572","journal-title":"Food Biosci"},{"key":"5033_CR275","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10989-017-9662-9","volume":"24","author":"V Arumugam","year":"2018","unstructured":"Arumugam V, Venkatesan M, Ramachandran S, Sundaresan U (2018) Bioactive peptides from marine ascidians and future drug development: A review. Int J Pept Res Ther 24:13\u201318","journal-title":"Int J Pept Res Ther"},{"key":"5033_CR276","doi-asserted-by":"publisher","first-page":"888360","DOI":"10.3389\/fnut.2022.888360","volume":"9","author":"A Carletti","year":"2022","unstructured":"Carletti A et al (2022) Antioxidant and anti-inflammatory extracts from sea cucumbers and tunicates induce a pro-osteogenic effect in zebrafish larvae. Front Nutr 9:888360","journal-title":"Front Nutr"},{"key":"5033_CR277","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0894-9166(15)60010-6","volume":"28","author":"R Huang","year":"2015","unstructured":"Huang R, Rong Q, Han X, Li Y (2015) The effects of cod bone gelatin on trabecular microstructure and mechanical properties of cancellous bone. Acta Mech Solida Sin 28:1\u201310","journal-title":"Acta Mech Solida Sin"},{"key":"5033_CR278","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.nut.2005.03.007","volume":"21","author":"Y Nomura","year":"2005","unstructured":"Nomura Y, Oohashi K, Watanabe M, Kasugai S (2005) Increase in bone mineral density through oral administration of shark gelatin to ovariectomized rats. Nutrition 21:1120\u20131126","journal-title":"Nutrition"},{"key":"5033_CR279","doi-asserted-by":"publisher","first-page":"1900861","DOI":"10.1002\/mnfr.201900861","volume":"64","author":"J Li","year":"2020","unstructured":"Li J et al (2020) Tuna bone powder alleviates glucocorticoid-induced osteoporosis via coregulation of the NF-\u03baB and Wnt\/\u03b2-Catenin signaling pathways and modulation of gut microbiota composition and metabolism. Mol Nutr Food Res 64:1900861","journal-title":"Mol Nutr Food Res"},{"key":"5033_CR280","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.3390\/md12105132","volume":"12","author":"F Karadeniz","year":"2014","unstructured":"Karadeniz F, Kim J-A, Ahn B-N, Kwon MS, Kong C-S (2014) Effect of Salicornia herbacea on osteoblastogenesis and adipogenesis in vitro. Mar Drugs 12:5132\u20135147","journal-title":"Mar Drugs"},{"key":"5033_CR281","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3746\/pnf.2014.19.3.187","volume":"19","author":"F Karadeniz","year":"2014","unstructured":"Karadeniz F, Kim J-A, Ahn B-N, Kim M, Kong C-S (2014) Anti-adipogenic and pro-osteoblastogenic activities of Spergularia marina extract. Prev Nutr Food Sci 19:187\u2013193","journal-title":"Prev Nutr Food Sci"},{"key":"5033_CR282","doi-asserted-by":"publisher","first-page":"719438","DOI":"10.3389\/fnut.2021.719438","volume":"8","author":"VP Roberto","year":"2021","unstructured":"Roberto VP et al (2021) Antioxidant, mineralogenic and osteogenic activities of Spartina alterniflora and Salicornia fragilis extracts rich in polyphenols. Front Nutr 8:719438","journal-title":"Front Nutr"},{"key":"5033_CR283","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/B978-0-12-816573-7.00006-7","volume-title":"Cellular and Animal Models in Human Genomics Research","author":"CP Canales","year":"2019","unstructured":"Canales CP, Walz K (2019) The mouse, a model organism for biomedical research. In: Walz K, Young JI (eds) Cellular and Animal Models in Human Genomics Research. Academic Press, UK, pp 119\u2013140"},{"key":"5033_CR284","first-page":"89","volume":"19","author":"N Yousefzadeh","year":"2020","unstructured":"Yousefzadeh N, Kashfi K, Jeddi S, Ghasemi A (2020) Ovariectomized rat model of osteoporosis: A practical guide. EXCLI J 19:89\u2013107","journal-title":"EXCLI J"},{"key":"5033_CR285","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jnutbio.2009.10.002","volume":"21","author":"GV Halade","year":"2010","unstructured":"Halade GV, Rahman MM, Williams PJ, Fernandes G (2010) High fat diet-induced animal model of age-associated obesity and osteoporosis. J Nutr Biochem 21:1162\u20131169","journal-title":"J Nutr Biochem"},{"key":"5033_CR286","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/bonekey.2014.109","volume":"3","author":"A Sophocleous","year":"2014","unstructured":"Sophocleous A, Idris AI (2014) Rodent models of osteoporosis. BoneKEy Rep 3:614","journal-title":"BoneKEy Rep"},{"key":"5033_CR287","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/ijms23010377","volume":"23","author":"A Xavier","year":"2022","unstructured":"Xavier A, Toumi H, Lespessailles E (2022) Animal model for glucocorticoid induced osteoporosis: A systematic review from 2011 to 2021. Int J Mol Sci 23:377","journal-title":"Int J Mol Sci"},{"key":"5033_CR288","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.bone.2015.08.012","volume":"81","author":"J-W Kim","year":"2015","unstructured":"Kim J-W, Tatad JCI, Landayan MEA, Kim S-J, Kim M-R (2015) Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease. Bone 81:442\u2013448","journal-title":"Bone"},{"key":"5033_CR289","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/bonekey.2013.233","volume":"3","author":"JA Eisman","year":"2014","unstructured":"Eisman JA, Bouillon R (2014) Vitamin D: Direct effects of vitamin D metabolites on bone: Lessons from genetically modified mice. BoneKEy Rep 3:499","journal-title":"BoneKEy Rep"},{"key":"5033_CR290","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1210\/en.2002-221000","volume":"144","author":"S Lotinun","year":"2003","unstructured":"Lotinun S, Sibonga JD, Turner RT (2003) Triazolopyrimidine (Trapidil), a platelet-derived growth factor antagonist, inhibits parathyroid bone disease in an animal model for chronic hyperparathyroidism. Endocrinology 144:2000\u20132007","journal-title":"Endocrinology"},{"key":"5033_CR291","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.bbrc.2018.03.038","volume":"498","author":"L-H Ni","year":"2018","unstructured":"Ni L-H et al (2018) A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet. Biochem Biophys Res Commun 498:654\u2013659","journal-title":"Biochem Biophys Res Commun"},{"key":"5033_CR292","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/jbmr.4275","volume":"36","author":"Z Wei","year":"2021","unstructured":"Wei Z et al (2021) Mutations in Profilin 1 cause early-onset Paget\u2019s disease of bone with giant cell tumors. J Bone Miner Res 36:1088\u20131103","journal-title":"J Bone Miner Res"},{"key":"5033_CR293","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/jbmr.4288","volume":"36","author":"N Alonso","year":"2021","unstructured":"Alonso N et al (2021) Insertion mutation in Tnfrsf11a causes a Paget\u2019s disease\u2013like phenotype in heterozygous mice and osteopetrosis in homozygous mice. J Bone Miner Res 36:1376\u20131386","journal-title":"J Bone Miner Res"},{"key":"5033_CR294","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ydbio.2019.07.009","volume":"457","author":"L Lleras-Forero","year":"2020","unstructured":"Lleras-Forero L, Winkler C, Schulte-Merker S (2020) Zebrafish and medaka as models for biomedical research of bone diseases. Dev Biol 457:191\u2013205","journal-title":"Dev Biol"},{"key":"5033_CR295","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/jbmr.4256","volume":"36","author":"K Dietrich","year":"2021","unstructured":"Dietrich K et al (2021) Skeletal biology and disease modeling in zebrafish. J Bone Miner Res 36:436\u2013458","journal-title":"J Bone Miner Res"},{"key":"5033_CR296","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/ph15080983","volume":"15","author":"JT Rosa","year":"2022","unstructured":"Rosa JT, Tarasco M, Gavaia PJ, Cancela ML, Laiz\u00e9 V (2022) Screening of mineralogenic and osteogenic compounds in zebrafish\u2014Tools to improve assay throughput and data accuracy. Pharmaceuticals 15:983","journal-title":"Pharmaceuticals"},{"key":"5033_CR297","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1387\/ijdb.082615sb","volume":"53","author":"SA Brittijn","year":"2009","unstructured":"Brittijn SA et al (2009) Zebrafish development and regeneration: New tools for biomedical research. Int J Dev Biol 53:835\u2013850","journal-title":"Int J Dev Biol"},{"key":"5033_CR298","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ddmod.2014.08.001","volume":"13","author":"V Laiz\u00e9","year":"2014","unstructured":"Laiz\u00e9 V, Gavaia PJ, Cancela ML (2014) Fish: A suitable system to model human bone disorders and discover drugs with osteogenic or osteotoxic activities. Drug Discov Today Dis Models 13:29\u201337","journal-title":"Drug Discov Today Dis Models"},{"key":"5033_CR299","doi-asserted-by":"publisher","first-page":"672424","DOI":"10.3389\/fcell.2021.672424","volume":"9","author":"JT Rosa","year":"2021","unstructured":"Rosa JT, Laiz\u00e9 V, Gavaia PJ, Cancela ML (2021) Fish models of induced osteoporosis. Front Cell Dev Biol 9:672424","journal-title":"Front Cell Dev Biol"},{"key":"5033_CR300","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cbpc.2015.08.007","volume":"178","author":"TT To","year":"2015","unstructured":"To TT, Witten PE, Huysseune A, Winkler C (2015) An adult osteopetrosis model in medaka reveals the importance of osteoclast function for bone remodeling in teleost fish. Comp Biochem Physiol Part C Toxicol Pharmacol 178:68\u201375","journal-title":"Comp Biochem Physiol Part C Toxicol Pharmacol"},{"key":"5033_CR301","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/jai.12523","volume":"30","author":"IAL Silva","year":"2014","unstructured":"Silva IAL, Concei\u00e7\u00e3o N, Michou L, Cancela ML (2014) Can zebrafish be a valid model to study Paget\u2019s disease of bone? J Appl Ichthyol 30:678\u2013688","journal-title":"J Appl Ichthyol"},{"key":"5033_CR302","doi-asserted-by":"publisher","first-page":"15866","DOI":"10.3390\/ijerph192315866","volume":"19","author":"NM Dubale","year":"2022","unstructured":"Dubale NM, Kapron CM, West SL (2022) Commentary: Zebrafish as a model for osteoporosis\u2014An approach to accelerating progress in drug and exercise-based treatment. Int J Environ Res Public Health 19:15866","journal-title":"Int J Environ Res Public Health"},{"key":"5033_CR303","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10811-016-0968-3","volume":"29","author":"G Surget","year":"2017","unstructured":"Surget G et al (2017) Marine green macroalgae: A source of natural compounds with mineralogenic and antioxidant activities. J Applied Phycol 29:575\u2013584","journal-title":"J Applied Phycol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-05033-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T15:04:27Z","timestamp":1703084667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-05033-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":303,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5033"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-05033-x","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"20 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No animals were used in the present study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No human research participants were involved in the present study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"11"}}